ES2558953B1 - Corn enriched in antioxidants to improve the nutritional quality of the egg - Google Patents
Corn enriched in antioxidants to improve the nutritional quality of the egg Download PDFInfo
- Publication number
- ES2558953B1 ES2558953B1 ES201531699A ES201531699A ES2558953B1 ES 2558953 B1 ES2558953 B1 ES 2558953B1 ES 201531699 A ES201531699 A ES 201531699A ES 201531699 A ES201531699 A ES 201531699A ES 2558953 B1 ES2558953 B1 ES 2558953B1
- Authority
- ES
- Spain
- Prior art keywords
- carotene
- seq
- sequence
- cryptoxanthin
- transgene encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000008042 Zea mays Species 0.000 title claims abstract description 113
- 235000002017 Zea mays subsp mays Nutrition 0.000 title claims abstract description 98
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title claims abstract description 97
- 235000005822 corn Nutrition 0.000 title claims abstract description 97
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 90
- 235000016709 nutrition Nutrition 0.000 title abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 124
- 241001057636 Dracaena deremensis Species 0.000 claims abstract description 100
- 239000002417 nutraceutical Substances 0.000 claims abstract description 72
- 235000021436 nutraceutical agent Nutrition 0.000 claims abstract description 72
- 235000013601 eggs Nutrition 0.000 claims abstract description 65
- 230000000050 nutritive effect Effects 0.000 claims abstract description 51
- 239000004212 Cryptoxanthin Substances 0.000 claims description 252
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 190
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 162
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 161
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 161
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 161
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 161
- 235000010930 zeaxanthin Nutrition 0.000 claims description 161
- 239000001775 zeaxanthin Substances 0.000 claims description 161
- 229940043269 zeaxanthin Drugs 0.000 claims description 161
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 149
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 148
- 235000012661 lycopene Nutrition 0.000 claims description 148
- 239000001751 lycopene Substances 0.000 claims description 148
- 229960004999 lycopene Drugs 0.000 claims description 148
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 148
- 108700019146 Transgenes Proteins 0.000 claims description 129
- 235000021466 carotenoid Nutrition 0.000 claims description 120
- 150000001747 carotenoids Chemical class 0.000 claims description 120
- 235000006708 antioxidants Nutrition 0.000 claims description 84
- 241000196324 Embryophyta Species 0.000 claims description 72
- 108090000623 proteins and genes Proteins 0.000 claims description 69
- 235000005473 carotenes Nutrition 0.000 claims description 50
- -1 lutema Chemical compound 0.000 claims description 48
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims description 46
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims description 46
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims description 45
- 235000013734 beta-carotene Nutrition 0.000 claims description 44
- 239000011648 beta-carotene Substances 0.000 claims description 44
- 150000001746 carotenes Chemical class 0.000 claims description 44
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 44
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 43
- 235000013793 astaxanthin Nutrition 0.000 claims description 43
- 239000001168 astaxanthin Substances 0.000 claims description 43
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 43
- 229940022405 astaxanthin Drugs 0.000 claims description 43
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 42
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 42
- 229960002747 betacarotene Drugs 0.000 claims description 42
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 42
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 39
- OOUTWVMJGMVRQF-NWYYEFBESA-N Phoenicoxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C OOUTWVMJGMVRQF-NWYYEFBESA-N 0.000 claims description 38
- 239000004213 Violaxanthin Substances 0.000 claims description 38
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 claims description 38
- 235000012682 canthaxanthin Nutrition 0.000 claims description 38
- FDSDTBUPSURDBL-DKLMTRRASA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-DKLMTRRASA-N 0.000 claims description 38
- 235000019245 violaxanthin Nutrition 0.000 claims description 38
- 230000003078 antioxidant effect Effects 0.000 claims description 36
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 claims description 29
- 239000011774 beta-cryptoxanthin Substances 0.000 claims description 28
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 27
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- 108010050792 glutenin Proteins 0.000 claims description 23
- 108010091656 beta-carotene hydroxylase Proteins 0.000 claims description 22
- 108010080924 beta-carotene ketolase Proteins 0.000 claims description 21
- 108091030071 RNAI Proteins 0.000 claims description 18
- OFNSUWBAQRCHAV-OYQUVCAXSA-N antheraxanthin Chemical compound C(/[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C OFNSUWBAQRCHAV-OYQUVCAXSA-N 0.000 claims description 18
- 230000009368 gene silencing by RNA Effects 0.000 claims description 18
- OFNSUWBAQRCHAV-UHFFFAOYSA-N 9-cis-antheraxanthin Natural products O1C(CC(O)CC2(C)C)(C)C12C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C OFNSUWBAQRCHAV-UHFFFAOYSA-N 0.000 claims description 17
- OFNSUWBAQRCHAV-MATJVGBESA-N Antheraxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@]23C(C)(C)C[C@H](O)C[C@@]2(C)O3)\C)/C)\C)/C)=C(C)C1 OFNSUWBAQRCHAV-MATJVGBESA-N 0.000 claims description 17
- 235000007164 Oryza sativa Nutrition 0.000 claims description 17
- 235000009566 rice Nutrition 0.000 claims description 17
- OFNSUWBAQRCHAV-KYHIUUMWSA-N zeaxanthin monoepoxide Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C OFNSUWBAQRCHAV-KYHIUUMWSA-N 0.000 claims description 17
- 108030000403 Lycopene epsilon-cyclases Proteins 0.000 claims description 16
- 241000287828 Gallus gallus Species 0.000 claims description 15
- 230000009261 transgenic effect Effects 0.000 claims description 15
- 108020004705 Codon Proteins 0.000 claims description 14
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 claims description 14
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 claims description 14
- 125000005340 bisphosphate group Chemical group 0.000 claims description 14
- 238000013518 transcription Methods 0.000 claims description 14
- 230000035897 transcription Effects 0.000 claims description 14
- 210000003763 chloroplast Anatomy 0.000 claims description 13
- 108020003589 5' Untranslated Regions Proteins 0.000 claims description 12
- 108700023224 Glucose-1-phosphate adenylyltransferases Proteins 0.000 claims description 12
- 244000144977 poultry Species 0.000 claims description 12
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 11
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 11
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 10
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 10
- 108010058731 nopaline synthase Proteins 0.000 claims description 10
- 229920002494 Zein Polymers 0.000 claims description 8
- 108020001507 fusion proteins Proteins 0.000 claims description 8
- 102000037865 fusion proteins Human genes 0.000 claims description 8
- 239000005019 zein Substances 0.000 claims description 8
- 229940093612 zein Drugs 0.000 claims description 8
- 108010049994 Chloroplast Proteins Proteins 0.000 claims description 6
- 230000008685 targeting Effects 0.000 claims description 5
- 235000008935 nutritious Nutrition 0.000 claims description 3
- 241000209094 Oryza Species 0.000 claims 4
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 claims 4
- YECXHLPYMXGEBI-ZNQVSPAOSA-N adonixanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C YECXHLPYMXGEBI-ZNQVSPAOSA-N 0.000 description 35
- SZCBXWMUOPQSOX-WVJDLNGLSA-N all-trans-violaxanthin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-WVJDLNGLSA-N 0.000 description 35
- YECXHLPYMXGEBI-DOYZGLONSA-N Adonixanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C YECXHLPYMXGEBI-DOYZGLONSA-N 0.000 description 34
- 210000002969 egg yolk Anatomy 0.000 description 29
- 235000019244 cryptoxanthin Nutrition 0.000 description 18
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 15
- 235000013305 food Nutrition 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 240000007594 Oryza sativa Species 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 235000005911 diet Nutrition 0.000 description 12
- 230000037213 diet Effects 0.000 description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 10
- 235000013345 egg yolk Nutrition 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 235000013330 chicken meat Nutrition 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000013594 poultry meat Nutrition 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000002322 Egg Proteins Human genes 0.000 description 7
- 108010000912 Egg Proteins Proteins 0.000 description 7
- 240000005979 Hordeum vulgare Species 0.000 description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- 235000007244 Zea mays Nutrition 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 6
- 150000001749 carotenones Chemical class 0.000 description 6
- 235000005472 carotenones Nutrition 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- 241000782624 Zema Species 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 229960003471 retinol Drugs 0.000 description 5
- 235000020944 retinol Nutrition 0.000 description 5
- 239000011607 retinol Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000271566 Aves Species 0.000 description 4
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
- 101150103518 bar gene Proteins 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 230000018883 protein targeting Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000013074 reference sample Substances 0.000 description 4
- 229930002330 retinoic acid Natural products 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 229960001727 tretinoin Drugs 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 240000003409 Gentiana lutea Species 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 240000000785 Tagetes erecta Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ATCICVFRSJQYDV-UHFFFAOYSA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C ATCICVFRSJQYDV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000061154 Brevundimonas sp. Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 241000272201 Columbiformes Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000002873 Gentiana lutea Nutrition 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000589598 Paracoccus sp. Species 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000012311 Tagetes erecta Nutrition 0.000 description 2
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 230000000485 pigmenting effect Effects 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000000979 retarding effect Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 150000003505 terpenes Chemical group 0.000 description 2
- 150000003735 xanthophylls Chemical class 0.000 description 2
- 235000008210 xanthophylls Nutrition 0.000 description 2
- DMASLKHVQRHNES-GMKWGACXSA-N (1s)-3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol Chemical compound C([C@@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-GMKWGACXSA-N 0.000 description 1
- NBZANZVJRKXVBH-DJPRRHJBSA-N (3R,6'R)-beta,epsilon-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=CCCC1(C)C NBZANZVJRKXVBH-DJPRRHJBSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- OINNEUNVOZHBOX-QIRCYJPOSA-N 2-trans,6-trans,10-trans-geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-QIRCYJPOSA-N 0.000 description 1
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 1
- WFPZSXYXPSUOPY-UHFFFAOYSA-N ADP-mannose Natural products C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O WFPZSXYXPSUOPY-UHFFFAOYSA-N 0.000 description 1
- 101150042430 ASA2 gene Proteins 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101150028535 CRTZ gene Proteins 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101000802989 Chlamydomonas reinhardtii Zeaxanthin 4-ketolase Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241001524109 Dietzia Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000271571 Dromaius novaehollandiae Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 241000168517 Haematococcus lacustris Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 101150054907 Mrps12 gene Proteins 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ATCICVFRSJQYDV-DDRHJXQASA-N Neurosporene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C ATCICVFRSJQYDV-DDRHJXQASA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 101150044053 PSY1 gene Proteins 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241000271570 Rhea americana Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100199945 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rps1201 gene Proteins 0.000 description 1
- 108010016634 Seed Storage Proteins Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101100061456 Streptomyces griseus crtB gene Proteins 0.000 description 1
- 101100242848 Streptomyces hygroscopicus bar gene Proteins 0.000 description 1
- 241000187191 Streptomyces viridochromogenes Species 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000209149 Zea Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 101150067314 aadA gene Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- NBZANZVJRKXVBH-GYDPHNCVSA-N alpha-Cryptoxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]2C(C)=CCCC2(C)C)\C)/C)\C)/C)=C(C)C1 NBZANZVJRKXVBH-GYDPHNCVSA-N 0.000 description 1
- 150000001373 alpha-carotenes Chemical class 0.000 description 1
- 235000005861 alpha-cryptoxanthin Nutrition 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 101150055766 cat gene Proteins 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 101150011633 crtI gene Proteins 0.000 description 1
- 101150079391 crtW gene Proteins 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000030414 genetic transfer Effects 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 235000008665 neurosporene Nutrition 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 231100001184 nonphytotoxic Toxicity 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 239000005304 optical glass Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 101150113864 pat gene Proteins 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 230000010152 pollination Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035115 protein targeting to chloroplast Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 101150015537 rps12 gene Proteins 0.000 description 1
- 101150098466 rpsL gene Proteins 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 1
- 235000019529 tetraterpenoid Nutrition 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Abstract
Maíz enriquecido en antioxidantes para mejorar la calidad nutricional del huevo.#La presente invención se relaciona con una composición nutritiva o nutracéutico que comprende una parte de una planta de maíz enriquecida en antioxidantes o un derivado de la misma y con los usos de dicha composición para la obtención de huevos enriquecidos en antioxidantes. La invención también se relaciona con el uso de una parte de una planta de maíz enriquecida en antioxidantes o un derivado de la misma para la obtención de huevos enriquecidos en antioxidantes. La invención se relaciona también con un huevo y ovoproductos derivados de dicho huevo obtenidos según los usos de la invención.Corn enriched in antioxidants to improve the nutritional quality of the egg. # The present invention relates to a nutritive or nutraceutical composition comprising a part of a corn plant enriched in antioxidants or a derivative thereof and with the uses of said composition for Obtaining eggs enriched in antioxidants. The invention also relates to the use of a part of a corn plant enriched in antioxidants or a derivative thereof for obtaining eggs enriched in antioxidants. The invention also relates to an egg and egg products derived from said egg obtained according to the uses of the invention.
Description
55
1010
15fifteen
20twenty
2525
DESCRIPCIONDESCRIPTION
MAIZ ENRIQUECIDO EN ANTIOXIDANTES PARA MEJORAR LA CALIDADRICH CORN IN ANTIOXIDANTS TO IMPROVE QUALITY
NUTRICIONAL DEL HUEVONUTRITIONAL OF EGG
CAMPO DE LA INVENCIONFIELD OF THE INVENTION
La presente invencion se encuadra en el campo de la tecnologia de alimentos y particularmente en el desarrollo de nuevos maices y la mejora de la calidad nutricional del huevo.The present invention falls within the field of food technology and particularly in the development of new corn and the improvement of the nutritional quality of the egg.
ANTECEDENTES DE LA INVENCIONBACKGROUND OF THE INVENTION
Los pigmentos carotenoides son compuestos responsables de la coloration de gran numero de alimentos vegetales y animales, como zanahorias, naranjas, tomates, salmon y yema de huevo. Desde hace muchos anos se sabe que algunos de estos compuestos como a y p- caroteno, asi como la p criptoxantina, son provitaminas A. No obstante, estudios recientes han puesto de manifiesto las propiedades antioxidantes de estos pigmentos, asi como su eficacia en la prevention de ciertas enfermedades del ser humano, como la aterosclerosis o incluso el cancer. Por otro lado, las observaciones epidemiologicas parecen indicar que el consumo de alimentos ricos en carotenoides esta relacionado con un menor riesgo de padecer enfermedades cronicas.Carotenoid pigments are compounds responsible for the coloration of large numbers of plant and animal foods, such as carrots, oranges, tomatoes, salmon and egg yolk. It has been known for many years that some of these compounds, such as a and p-carotene, as well as p-cryptoxanthin, are provitamins A. However, recent studies have shown the antioxidant properties of these pigments, as well as their effectiveness in prevention of certain diseases of the human being, such as atherosclerosis or even cancer. On the other hand, epidemiological observations seem to indicate that the consumption of foods rich in carotenoids is related to a lower risk of chronic diseases.
Se ha comprobado que los carotenoides potencian tanto las funciones inmunologicas espedficas como las no espedficas. Diversas reacciones de modulation inmunologicas pueden aumentar la actividad tumoricida de las celulas T citotoxicas, los macrofagos y/o las celulas asesinas naturales y fomentar las funciones antimicrobianas inmunologicas. Por ejemplo, el beta-caroteno puede reducir la incidencia de sucesos cardiovasculares, habiendose demostrado en estudios clmicos. Adicionalmente los grupos de poblacion que consumen alimentos ricos en beta-caroteno estan mas protegidos contra los canceres de piel y pulmon, particularmente los fumadores. Se han propuesto varios mecanismos para explicar la actividad fisiologica de los carotenoides. La mas plausible se basa en el fuerte caracter antioxidante y en su capacidad para desactivar sustancias qdmicas perjudiciales como el oxigeno singlete, los radicales libres y los radicales peroxido lipidicos. TambienCarotenoids have been shown to potentiate both specific and non-specific immunological functions. Various immunological modulation reactions can increase the tumoricidal activity of cytotoxic T cells, macrophages and / or natural killer cells and promote immunological antimicrobial functions. For example, beta-carotene can reduce the incidence of cardiovascular events, having been demonstrated in clinical studies. Additionally, population groups that consume foods rich in beta-carotene are more protected against skin and lung cancers, particularly smokers. Several mechanisms have been proposed to explain the physiological activity of carotenoids. The most plausible is based on the strong antioxidant character and its ability to deactivate harmful chemicals such as singlet oxygen, free radicals and lipid peroxide radicals. Too
55
1010
15fifteen
20twenty
2525
hay evidencia de que varios carotenoides producen una estimulacion directa del sistema inmunologico y de la respuesta inmunologica.There is evidence that several carotenoids produce a direct stimulation of the immune system and the immune response.
Todo ello ha hecho que desde un punto de vista nutricional, el interes por estos pigmentos se haya incrementado notoriamente.All this has meant that from a nutritional point of view, interest in these pigments has increased markedly.
El consumo de huevos de ave y muy especialmente de gallina (92% del total mundial, FAO 2012) esta extendido en todo el mundo, siendo un elemento esencial en la dieta de muchas personas representando un aporte de carotenoides importante. Durante el ano 2012, se consumieron en todo el mundo casi 72 MT de huevo, de ellos mas de 66 MT eran de huevo de gallina (FAO, 2012). Los consumidores aprecian un color elevado en la gama amarillo-naranja en la yema del huevo, considerando esta caracteristica como determinante en el momento de la compra y como reflejo de la calidad de los huevos.The consumption of poultry eggs and especially chicken (92% of the world total, FAO 2012) is widespread throughout the world, being an essential element in the diet of many people representing an important contribution of carotenoids. During 2012, almost 72 MT of eggs were consumed worldwide, of which more than 66 MT were from chicken eggs (FAO, 2012). Consumers appreciate a high color in the yellow-orange range in the egg yolk, considering this characteristic as a determinant at the time of purchase and as a reflection of the quality of the eggs.
La utilization de carotenoides en avicultura va mas alla de sus propiedades pigmentantes de la yema del huevo y la piel y patas de los pollos. A parte del efecto pigmentante estos carotenoides tambien cumplen una serie de funciones importantes en el animal. Asi se conocen sus efectos antioxidantes, estimuladores del sistema inmunitario y sobre la mejora de los parametros productivos de las aves, especialmente en la eficacia reproductiva y la obtencion de pollitos viables, asi como actuando como precursores de la vitamina A.The utilization of carotenoids in poultry goes beyond its pigmenting properties of egg yolk and the skin and legs of chickens. Apart from the pigmenting effect, these carotenoids also fulfill a series of important functions in the animal. Thus, its antioxidant effects, immune system stimulators and the improvement of the productive parameters of the birds are known, especially in the reproductive efficiency and the obtaining of viable chicks, as well as acting as precursors of vitamin A.
Las gallinas pueden depositar carotenoides en la yema del huevo y son estos carotenoides los que le daran el color tipico. Puesto que las gallinas no pueden sintetizar estas moleculas, es obligado que sean aportadas por la dieta, fundamentalmente por el maiz, la alfalfa y otros vegetales verdes.The hens can deposit carotenoids in the yolk of the egg and it is these carotenoids that will give it the typical color. Since hens cannot synthesize these molecules, it is mandatory that they be contributed by the diet, mainly by corn, alfalfa and other green vegetables.
La composition de las diferentes dietas que habitualmente se suministran a las gallinas, aunque incluyan materias primas ricas en carotenoides, no logran una concentration suficiente en la yema para satisfacer las exigencias del consumidor, siendo necesario anadirlos en forma de aditivos, que se obtienen por extraction a partir de los petalos de la flor de marigold (Tagetes erecta), o bien a partir de smtesis quimica.The composition of the different diets that are usually supplied to chickens, even if they include raw materials rich in carotenoids, do not achieve a sufficient concentration in the yolk to meet the requirements of the consumer, being necessary to add them in the form of additives, which are obtained by extraction from the marigold flower petals (Tagetes erecta), or from chemical synthesis.
Sin embargo estas fuentes de carotenoides presentan desventajas, ya que los carotenoides de maiz son mas biodisponibles que los de Tagetes erecta y la smtesisHowever, these sources of carotenoids have disadvantages, since corn carotenoids are more bioavailable than those of Tagetes erecta and the synthesis
55
1010
15fifteen
20twenty
2525
3030
qmmica de carotenoides requiere un gran nivel de control y puede producir compuestos con efectos indeseables y que pueden ser alergenos en ciertos consumidores.Carotenoid chemistry requires a high level of control and can produce compounds with undesirable effects and which may be allergens in certain consumers.
Por tanto, como alternativa se tratan de identificar otras fuentes de carotenoides como los pigmentos obtenidos a partir de biomasa de levadura Phaffia rhodozyma, del alga Haematococcus pluvialis, Chrlorococcum sp o de bacteria Dietzia natronolimnacea (Esfahani-mashhopur M. et al., Asian-Aust. J. Anim. Sci. Vol. 22, No. 2: 254 - 259). Sin embargo existen pocos microrganismos capaces de satisfacer las demandas.Therefore, as an alternative they try to identify other sources of carotenoids such as pigments obtained from Phaffia rhodozyma yeast biomass, Haematococcus pluvialis algae, Chrlorococcum sp or Dietzia natronolimnacea bacteria (Esfahani-mashhopur M. et al., Asian- Aust. J. Anim. Sci. Vol. 22, No. 2: 254-259). However, there are few microorganisms capable of satisfying the demands.
El suplemento del alimento de gallinas ponedoras con distintas variedades de zanahorias consigue incrementar el contenido en carotenoides del huevo, sin embargo se reduce la ingesta en las gallinas lo que da lugar a que el peso de los huevos obtenidos y de la yema disminuye al suplementar con cualquiera de las variedades ensayadas e incluso se reduce la tasa de puesta (Hammershoj M. et al., J Sci Food Agric 2010; 90: 1163-1171).The food supplement of laying hens with different varieties of carrots manages to increase the carotenoid content of the egg, however the intake in the hens is reduced which results in the weight of the eggs obtained and the yolk decreases when supplemented with any of the varieties tested and even the laying rate is reduced (Hammershoj M. et al., J Sci Food Agric 2010; 90: 1163-1171).
Por tanto, existe la necesidad de encontrar alternativas para la obtencion huevos con una mejor calidad nutricional y particularmente enriquecerlos en antioxidantes.Therefore, there is a need to find alternatives for obtaining eggs with better nutritional quality and particularly enrich them in antioxidants.
COMPENDIO DE LA INVENCIONSUMMARY OF THE INVENTION
En un primer aspecto la invencion se relaciona con una composicion nutritiva o nutraceutico que comprende una parte de una planta de maiz enriquecida en antioxidantes o un derivado de la misma.In a first aspect the invention relates to a nutritive or nutraceutical composition comprising a part of a corn plant enriched in antioxidants or a derivative thereof.
En un segundo aspecto, la invencion se relaciona con el uso de una composicion nutritiva o nutraceutico de la invencion para la obtencion de huevos enriquecidos en antioxidantes.In a second aspect, the invention relates to the use of a nutritive or nutraceutical composition of the invention for obtaining eggs enriched in antioxidants.
En un tercer aspecto, la invencion se relaciona con el uso de una parte de una planta de maiz enriquecida en antioxidantes o un derivado de la misma para la obtencion de huevos enriquecidos en antioxidantes.In a third aspect, the invention relates to the use of a part of a corn plant enriched in antioxidants or a derivative thereof for obtaining eggs enriched in antioxidants.
En un cuarto aspecto, la invencion se relaciona con un huevo y ovoproductos derivados de dicho huevo obtenidos segun los usos de la invencion.In a fourth aspect, the invention relates to an egg and egg products derived from said egg obtained according to the uses of the invention.
BREVE DESCRIPCION DE LAS FIGURASBRIEF DESCRIPTION OF THE FIGURES
55
1010
15fifteen
20twenty
2525
3030
Figura 1. Carotenoides en el pienso en ^g/g de pienso (5 determinaciones).Figure 1. Carotenoids in feed in ^ g / g of feed (5 determinations).
Figura 2. Carotenoides en la yema de los huevos a los 31 d^as del experimento. Los valores son la media ± error estandar de 5 muestras *C427 es B-cryptoxantina-5,8- epoxido.Figure 2. Carotenoids in egg yolk at 31 days after the experiment. Values are the mean ± standard error of 5 samples * C427 is B-cryptoxanthin-5,8-epoxide.
Figura 3. Carotenoides en higado de gallina al final del experimento. Los valores son la media ± error estandar de 5 muestras. *C450 es B-caroteno-5,6-epoxido or B-carotene- 5,6,5’,6’-diepoxido. M37W-Ph3 es la lmea enriquecida en antioxidantes.Figure 3. Carotenoids in chicken liver at the end of the experiment. Values are the mean ± standard error of 5 samples. * C450 is B-carotene-5,6-epoxide or B-carotene-5,6,5 ’, 6’-diepoxide. M37W-Ph3 is the antioxidant enriched lmea.
Figura 4. Carotenoides en dgado de gallina al final del experimento sin retinol para poder observar los demas valores en otra escala. *C450 principalmente B-carotene-5,6-epoxido o B-carotene-5,6,5’,6’-diepoxido.Figure 4. Carotenoids in hen endowed at the end of the experiment without retinol in order to observe the other values on another scale. * C450 mainly B-carotene-5,6-epoxide or B-carotene-5,6,5 ’, 6’-diepoxide.
DESCRIPCION DETALLADADETAILED DESCRIPTION
Los autores de la presente invencion han conseguido mejorar la calidad nutricional del huevo alimentando las gallinas con variedades de maiz enriquecidas en antioxidantes (Ejemplo 1).The authors of the present invention have been able to improve the nutritional quality of the egg by feeding the hens with corn varieties enriched in antioxidants (Example 1).
DefinicionesDefinitions
El termino “composicion nutritiva” de la presente invencion se refiere a aquel alimento que, con independencia de aportar nutrientes al sujeto que lo toma, afecta beneficiosamente a una o varias funciones del organismo, de manera que proporciona un mejor estado de salud y bienestar. Como consecuencia, dicha composicion nutritiva puede ser destinada a la prevention y/o tratamiento de una enfermedad o del factor causante de una enfermedad. Por tanto, el termino “composicion nutritiva” de la presente invencion se puede emplear como sinonimo de alimento funcional o alimento para fines nutricionales espedficos o alimento medicinal. Una composicion nutritiva tiene una apariencia similar a la de un alimento convencional y se consume como parte de una dieta normal.The term "nutritional composition" of the present invention refers to that food that, regardless of providing nutrients to the subject who takes it, beneficially affects one or more functions of the organism, so that it provides a better state of health and well-being. As a consequence, said nutritional composition may be intended for the prevention and / or treatment of a disease or the causative factor of a disease. Therefore, the term "nutritional composition" of the present invention can be used as a synonym for functional food or food for specific nutritional purposes or medicinal food. A nutritional composition has an appearance similar to that of a conventional food and is consumed as part of a normal diet.
Por “nutraceutico”, palabra derivada de nutrition y farmaceutico, se entiende un producto elaborado a partir de un alimento, pero que se encuentra a modo de ejemplo ilustrativo noBy "nutraceutical", a word derived from nutrition and pharmaceutical, is meant a product made from a food, but found as an illustrative example not
55
1010
15fifteen
20twenty
2525
3030
limitativo, en forma de pfldora, polvos y otras presentaciones farmaceuticas no asociadas generalmente con los alimentos y que presenta propiedades beneficiosas para el tratamiento y/o prevention de enfermedades.limiting, in the form of pfldora, powders and other pharmaceutical presentations not generally associated with food and presenting beneficial properties for the treatment and / or prevention of diseases.
Por “planta de maiz”, segun se emplea en la presente invention, se refiere a un ser vivo fotosintetico perteneciente a la especie Zea mays. Dicho termino incluye tambien las diversas subespecies.By "corn plant", as used in the present invention, it refers to a photosynthetic living being belonging to the Zea mays species. Said term also includes the various subspecies.
Una “parte de una planta”, tal y como se usa en la presente invencion, se refiere a una parte espedfica de una planta, tal como tallo, hoja, raiz, flor, semilla, endospermo, grano, fruto o yema.A "part of a plant", as used in the present invention, refers to a specific part of a plant, such as stem, leaf, root, flower, seed, endosperm, grain, fruit or yolk.
“Derivado de una parte de la planta” se refiere a un producto obtenido tras el procesamiento de una parte de la planta de la invencion a partir de la modification fisica y/o qdmica, a modo ilustrativo no limitativo, harina, semola, aceite, sirope, almidon o fecula. Dicho termino no incluye un antioxidante aislado."Derived from a part of the plant" refers to a product obtained after the processing of a part of the plant of the invention from the physical and / or chemical modification, by way of illustration, not limitation, flour, semolina, oil, syrup, starch or facula. Said term does not include an isolated antioxidant.
Segun la invencion, la planta de maiz se encuentra “enriquecida en antioxidantes”, es decir, presenta niveles superiores de moleculas capaces de retardar o prevenir la oxidation de otras moleculas, comparado con un nivel de referencia. Los antioxidantes se encargan de capturar los radicales libres producidos en las reacciones de oxidacion propias del metabolismo. Ejemplos ilustrativos no limitativos de antioxidantes son carotenoides, lutema, licopeno, selenio, vitamina A, vitamina C y vitamina E.According to the invention, the corn plant is "enriched in antioxidants," that is, it has higher levels of molecules capable of retarding or preventing oxidation of other molecules, compared to a reference level. Antioxidants are responsible for capturing free radicals produced in the oxidation reactions of the metabolism. Illustrative non-limiting examples of antioxidants are carotenoids, lutema, lycopene, selenium, vitamin A, vitamin C and vitamin E.
“Semilla” tal y como se usa en la presente invencion, se refiere a cada uno de los cuerpos que forman parte del fruto que da origen a una nueva planta."Seed" as used in the present invention, refers to each of the bodies that are part of the fruit that gives rise to a new plant.
El termino “endospermo”, segun se usa en la presente invencion, se refiere al organo principal de almacenamiento en las semillas de maiz, nutriendo el embrion mientras la semilla se desarrolla y proporcionando nutrientes a la planta joven en germination.The term "endosperm," as used in the present invention, refers to the main organ of storage in corn seeds, nourishing the embryo while the seed develops and providing nutrients to the young germination plant.
55
1010
15fifteen
20twenty
2525
3030
Por “derivado de semilla o endospermo”, tal y como se usa en la presente invencion se refiere a cualquier producto obtenido a partir de la modification fisica y/o qwmica de la semilla o endospermo.By "seed derivative or endosperm", as used in the present invention it refers to any product obtained from the physical and / or chemical modification of the seed or endosperm.
El termino "harina" segun se entiende en la presente invencion, es el producto obtenido de la molturacion de cualquier semilla de plantas del genero Zea que puede estar despojado en mayor o menor grado del salvado o la cascarilla de la semilla.The term "flour" as understood in the present invention, is the product obtained from the milling of any seed of plants of the Zea genus that may be stripped to a greater or lesser extent of the bran or seed husk.
El termino "semola" hace referencia a harina gruesa (semillas de maiz poco molidas), es decir, fragmentos de endospermo con una cantidad variable de cascarilla de semilla.The term "semolina" refers to coarse flour (poorly ground corn seeds), that is, endosperm fragments with a variable amount of seed husk.
“Aceite de maiz”, tal y como se usa en la presente invencion, se refiere al aceite obtenido tras el secado del grano de maiz germinado."Corn oil", as used in the present invention, refers to the oil obtained after drying the germinated corn grain.
Por “almidon de maiz”. tal y como se emplea, se refiere a un polvo sedoso blanco finalmente molido hecho del endospermo del maiz seco.By "corn starch". As used, it refers to a finally ground white silky powder made from the dry corn endosperm.
“Fecula de maiz” es el polisacarido obtenido a traves de la molienda humeda."Corn flake" is the polysaccharide obtained through wet milling.
“Sirope de maiz”, tambien conocido como jarabe de maiz, es un edulcorante liquido elaborado a partir del almidon o la fecula de maiz tras un proceso de calentamiento e hidrolizacion."Corn syrup", also known as corn syrup, is a liquid sweetener made from starch or corn starch after a heating and hydrolyzing process.
“Carotenoides”, tal y como se usa en la presente invencion, se refiere a pigmentos organicos que se encuentran de forma natural en plantas y otros organismos fotosmteticos. La mayoria de los carotenoides son tetraterpenoides, compuestos de 40 atomos de carbono formados por ocho unidades isoprenoides y contienen anillos a uno o ambos extremos de la molecula. Pueden funcionar como antioxidantes, protegiendo frente a la auto-oxidacion."Carotenoids," as used in the present invention, refers to organic pigments found naturally in plants and other photosynthetic organisms. The majority of carotenoids are tetraterpenoids, composed of 40 carbon atoms formed by eight isoprenoid units and contain rings at one or both ends of the molecule. They can function as antioxidants, protecting against self-oxidation.
“B-caroteno” tal y como se usa en la presente invencion se refiere al carotenoide mas abundante en la naturaleza, precursor de la vitamina A con numero CAS 12-88-4."B-carotene" as used in the present invention refers to the most abundant carotenoid in nature, a precursor to vitamin A with CAS number 12-88-4.
55
1010
15fifteen
20twenty
2525
3030
“v-caroteno”, segun la presente invencion se refiere al carotenoide con numero CAS 47293-5."V-carotene", according to the present invention refers to the carotenoid with CAS number 47293-5.
“a-caroteno” tal y como se usa en la presente invencion, se refiere al carotenoide precursor de la vitamina A con numero CAS 7488-99-5"A-carotene" as used in the present invention, refers to the vitamin A precursor carotenoid with CAS number 7488-99-5
“a-criptoxantina”, segun la presente invencion, se refiere al carotenoide con numero CAS 472-70-8"A-cryptoxanthin", according to the present invention, refers to the carotenoid with CAS number 472-70-8
“B-criptoxantina”, tal y como se usa en la presente invencion, se refiere al compuesto con numero CAS 472-70-8."B-cryptoxanthin", as used in the present invention, refers to the compound with CAS number 472-70-8.
“licopeno” tal y como se usa en la presente invencion, se refiere al pigmento vegetal liposoluble con numero CAS 502-65-8 de color rojo."Lycopene" as used in the present invention refers to the fat-soluble plant pigment with CAS number 502-65-8 of red color.
“Luteina” tal y como se usa en la presente invencion se refiere a un derivado dihidroxilado del a-caroteno de color amarillo con numero CAS 127-40-2."Lutein" as used in the present invention refers to a dihydroxylated derivative of yellow a-carotene with CAS number 127-40-2.
“Zeaxantina”, tal y como se emplea en la presente invencion se refiere al pigmento liposoluble de color amarillo con numero CAS 144-68-3."Zeaxanthin", as used herein, refers to the yellow fat-soluble pigment with CAS number 144-68-3.
Por “planta de maiz transgenica”, segun se usa en la presente invencion, se refiere a aquella planta de maiz cuyo genoma ha sido modificado mediante ingenieria genetica con el objetivo de conseguir caracteristicas biologicas diferentes y/o mejoradas respecto a las de la planta isogenica silvestre.By "transgenic corn plant", as used in the present invention, refers to that corn plant whose genome has been modified by genetic engineering in order to achieve different and / or improved biological characteristics with respect to those of the isogenic plant wild.
Por “transgen” tal y como se usa en la presente invencion, se refiere a una secuencia que codifica un gen de un organismo que ha sido incorporado en el genoma de otro organismo de la misma o diferente especie. El organismo resultante se le denomina transgenico.By "transgene" as used in the present invention, it refers to a sequence that encodes a gene of an organism that has been incorporated into the genome of another organism of the same or different species. The resulting organism is called transgenic.
Por “Fitoeno sintasa” o psyl tal y como se usa en la presente invencion se refiere al gen que codifica para la enzima que cataliza la reaction que convierte dos moleculas de GGDP en fitoeno, el primer paso en la smtesis de la provitamina A. La secuencia queBy "Phytoeno synthase" or psyl as used in the present invention it refers to the gene that codes for the enzyme that catalyzes the reaction that converts two GGDP molecules into phytoene, the first step in the synthesis of provitamin A. sequence that
55
1010
15fifteen
20twenty
2525
3030
codifica para la fitoeno sintasa de Zea mays tiene la secuencia mostrada en SEQ ID NO: 1.encodes for Zea mays phytoeno synthase has the sequence shown in SEQ ID NO: 1.
“Caroteno desaturasa” o crtI, tal y como se usa en la presente invencion, se refiere al gen que codifica para la enzima encargada de la production de licopeno a partir de tres substratos, neurosporeno, un aceptor de electrones y oxigeno. La secuencia que codifica para la caroteno desaturasa de E eurodovora tiene la secuencia mostrada en SEQ ID NO: 2."Carotene desaturase" or crtI, as used in the present invention, refers to the gene that codes for the enzyme responsible for the production of lycopene from three substrates, neurosporene, an electron acceptor and oxygen. The sequence coding for E eurodovora carotene desaturase has the sequence shown in SEQ ID NO: 2.
“Licopeno B-ciclasa” o Lycb, tal y como se usa en la presente invencion, se refiere al gen que codifica para la enzima que transforma el licopeno en provitamina A. La secuencia que codifica para la Licopeno B-ciclasa de G. lutea tiene la secuencia mostrada en SEQ ID NO: 3."Lycopene B-cyclase" or Lycb, as used in the present invention, refers to the gene that codes for the enzyme that transforms lycopene into provitamin A. The sequence that codes for Lycopene B-cyclase from G. lutea It has the sequence shown in SEQ ID NO: 3.
“B-caroteno hidroxilasa” o bch, tal y como se usa en la presente invencion, se refiere al gen que codifica para la enzima encargada de la conversion del beta-caroteno a xantofilas. La secuencia que codifica para la B-caroteno hidroxilasa de Z. mays tiene la secuencia mostrada en SEQ ID NO: 4."B-carotene hydroxylase" or bch, as used in the present invention, refers to the gene that codes for the enzyme responsible for the conversion of beta-carotene to xanthophylls. The sequence coding for Z. mays B-carotene hydroxylase has the sequence shown in SEQ ID NO: 4.
“Carotenoide cetolasa” o crtw tal y como se usa en la presente invencion, se refiere al gen que codifica para la enzima encargada de anadir un grupo carbonilo con el carbono 4 y 4 'de la molecula de beta caroteno._La secuencia que codifica para la carotenoide cetolasa de Paracoccus sp. tiene la secuencia mostrada en SEQ ID NO:7."Carotenoid ketolase" or crtw as used in the present invention, refers to the gene that codes for the enzyme responsible for adding a carbonyl group with carbon 4 and 4 'of the beta carotene molecule. the carotenoid ketolase of Paracoccus sp. It has the sequence shown in SEQ ID NO: 7.
Por “secuencia para el direccionamiento de proteinas al cloroplasto”, tal y como se usa en la presente invencion se refiere a secuencias de importation al cloroplasto, estoma y que generalmente son secuencias ricas en Ser, Thr y residuos hidrofobicos pequenos y de bajo contenido de Glu y Asp. Dicha secuencia se situa en el extremo N-terminal dentro de la protema y es eliminada tras el direccionamiento. Ejemplos ilustrativos, no limitativos de dichas secuencias son aquellas presentes en enzimas del ciclo de Calvin y que son codificadas por genes nucleares y transportas al cloroplasto despues de su smtesis en el citosol, por ejemplo todas las demas enzimas del ciclo de Calvin, excepto la subunidad grande de la Rubisco.By "sequence for the targeting of proteins to chloroplast", as used in the present invention, it refers to sequences of importation to chloroplast, stoma and which are generally sequences rich in Ser, Thr and small and low content hydrophobic residues of low Glu and Asp. Said sequence is located at the N-terminal end within the shield and is eliminated after addressing. Illustrative, non-limiting examples of such sequences are those present in enzymes of the Calvin cycle and which are encoded by nuclear genes and transported to the chloroplast after their synthesis in the cytosol, for example all other enzymes of the Calvin cycle, except the subunit Big of the Rubisco.
55
1010
15fifteen
20twenty
2525
3030
“La subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa”, tal y como se emplea en la presente invention, se refiere a la subunidad reguladora. La secuencia correspondiente a la protema en guisante tiene el numero de acceso P00868 de la base de datos de Uniprot a fecha 14 de octubre de 2015."The small subunit of Ribulose 1,5 bisphosphate Carboxylase-Oxygenase", as used in the present invention, refers to the regulatory subunit. The pea protein sequence has access number P00868 from the Uniprot database as of October 14, 2015.
“Secuencia terminadora de la transcription” o senal de parada, tal y como se usa en la presente invencion, se refiere a una secuencia en el ADN que cuando es reconocida por la ARN polimerasa, el ARNm se separa y se interrumpe la smtesis de ARNm"Transcription terminator sequence" or stop signal, as used in the present invention, refers to a sequence in the DNA that when recognized by RNA polymerase, the mRNA is separated and mRNA synthesis is interrupted.
“Nopalina sintasa”, tal y como se usa en la presente invencion se refiere a una protema con actividad oxidoreductasa y cuya secuencia de Agrobacterium tumefaciens corresponde con la secuencia con numero de acceso WP_032488658. 1 en la base de datos de Genbank a fecha 8 de octubre de 2014"Nopalin synthase", as used in the present invention, refers to a protein with oxidoreductase activity and whose sequence of Agrobacterium tumefaciens corresponds to the sequence with access number WP_032488658. 1 in the Genbank database as of October 8, 2014
“ADP-glucosa pirofosforilasa” La secuencia correspondiente a la protema en arroz tiene el numero de acceso BAF80188.1 de la base de datos de Genbank a fecha 29 de diciembre de 2014.“ADP-glucose pyrophosphorylase” The sequence corresponding to the protein in rice has accession number BAF80188.1 from the Genbank database as of December 29, 2014.
“Promotor espetifico de endospermo”, tal y como se usa en la presente invencion, se refiere a una molecula de acido nucleico que permite dirigir o regular la expresion de un gen en el endospermo. El “endospermo” es una formation caracteristica de las semillas de Angiospermas, es un tejido nutritivo para el embrion. El endospermo de maiz se origina a partir de una serie de divisiones nucleares libres, seguidas de la celularizacion y posterior formacion de un rango de dominios celulares funcionales. El endospermo es el organo de almacenamiento principal de las semillas de maiz; nutre al embrion mientras la semilla se desarrolla y proporciona nutrientes a la plantula en germination."Specific endosperm promoter", as used in the present invention, refers to a nucleic acid molecule that allows directing or regulating the expression of a gene in the endosperm. The "endosperm" is a characteristic formation of Angiosperm seeds, it is a nutritious tissue for the embryo. The corn endosperm originates from a series of free nuclear divisions, followed by cellization and subsequent formation of a range of functional cell domains. The endosperm is the main storage organ of corn seeds; It nourishes the embryo while the seed develops and provides nutrients to the germination plant.
“D-hordema de cebada”, tal y como se emplea en la presente invencion, se refiere a la protema con el numero de acceso Q40054 de la base de datos Uniprot a fecha 14 de octubre de 2015. En una realization particular, el promotor de D-hordema tiene la secuencia mostrada en SEQ ID NO: 12."D-hordema of barley", as used in the present invention, refers to the protein with accession number Q40054 of the Uniprot database as of October 14, 2015. In a particular embodiment, the promoter of D-hordema has the sequence shown in SEQ ID NO: 12.
55
1010
15fifteen
20twenty
2525
3030
“LMW glutenina de trigo”, tal y como se emplea en la presente invencion, se refiere a protema con el numero de acceso Q41603 de la base de datos Uniprot a fecha 14 de o octubre de 2015. En una realization particular, el promotor de LMW de glutenina tiene la secuencia mostrada en SEQ ID NO: 11."LMW wheat glutenin", as used in the present invention, refers to protema with accession number Q41603 from the Uniprot database as of October 14, 2015. In a particular embodiment, the promoter of LMW of glutenin has the sequence shown in SEQ ID NO: 11.
“Gamma zeina”, tal y como se usa en la presente invencion, se refiere a una protema de reserva de maiz y que corresponde a la secuencia con numero de acceso Q548E9 en la base de datos de Uniprot en fecha 14 de octubre de 2015."Gamma zeina", as used in the present invention, refers to a corn reserve protein and corresponding to the sequence with access number Q548E9 in the Uniprot database on October 14, 2015.
“Astaxantina”, segun la presente invencion es un carotenoide perteneciente a la serie fitoquimica de los terpenos con numero CAS 472-61-7."Astaxanthin", according to the present invention is a carotenoid belonging to the phytochemical series of terpenes with CAS number 472-61-7.
“Violaxantina”, tal y como se usa en la presente invencion se refiere a un derivado del alfa y beta caroteno con numero CAS 126-29-4."Violaxanthin", as used in the present invention refers to a derivative of alpha and beta carotene with CAS number 126-29-4.
“Anteraxantina”, se refiere a un pigmento amarillo con numero CAS 640-03-9."Anteraxanthin" refers to a yellow pigment with CAS number 640-03-9.
“Cantaxantina”, tal y como se usa en la presente invencion se refiere al compuesto con numero CAS 514-78-3."Cantaxanthin", as used in the present invention refers to the compound with CAS number 514-78-3.
“Adonixantina”, corresponde al compuesto con numero CAS 4418-73-9."Adonixanthin" corresponds to the compound with CAS number 4418-73-9.
“Adonirubina”, segun la presente invencion se refiere al compuesto con numero CAS 4418-72-8."Adonirubin", according to the present invention refers to the compound with CAS number 4418-72-8.
“3-OH equinenona”, se refiere al compuesto producto de la enzima EC 1.14.13."3-OH equinenone" refers to the compound product of the enzyme EC 1.14.13.
“Zeaxantina”, tal y como se usa en la presente invencion se refiere a un carotenoide de color amarillo del grupo de las xantofilas con numero CAS 114-68-3."Zeaxanthin", as used in the present invention, refers to a yellow carotenoid of the group of xanthophylls with CAS number 114-68-3.
“Z-fitoeno”, se refiere al compuesto con numero CAS 540-04-5."Z-phytoen" refers to the compound with CAS number 540-04-5.
55
1010
15fifteen
20twenty
2525
3030
“Fitoeno”, segun se emplea en la presente invencion, se refiere a un intermedio de 40 atomos de carbono en la biosmtesis de carotenoides."Phytoeno", as used in the present invention, refers to an intermediate of 40 carbon atoms in the biosynthesis of carotenoids.
“Beta caroteno cetolasa”, tal y como se emplea en la presente invencion, se refiere a la enzima codifica por el gen crtW y que cataliza las dos etapas de introduction del grupo oxo en el anillo de beta-yonona del beta-caroteno por ambos extremos. La secuencia que codifica para la beta caroteno cetolasa de C. reinhardtii tiene la secuencia mostrada en SEQ ID NO: 14."Beta carotene ketolase", as used in the present invention, refers to the enzyme encoded by the crtW gene and which catalyzes the two stages of introduction of the oxo group into the beta-yonone ring of beta-carotene by both extremes The sequence coding for C. reinhardtii beta carotene ketolase has the sequence shown in SEQ ID NO: 14.
“Beta caroteno hidroxilasa”, tal y como se emplea en la presente invencion se refiere a la enzima codificada por el gen crtZ y que interviene en las dos etapas de hidroxilacion del anillo de beta-yonona del beta caroteno en ambos extremos. La secuencia que codifica para la beta caroteno hidroxilasa de Brevidomonas sp. tiene la secuencia mostrada en SEQ ID NO:15."Beta carotene hydroxylase", as used in the present invention, refers to the enzyme encoded by the crtZ gene and which is involved in the two stages of hydroxylation of the beta-yonone ring of beta carotene at both ends. The sequence that codes for the beta carotene hydroxylase of Brevidomonas sp. It has the sequence shown in SEQ ID NO: 15.
“Licopeno epsilon ciclasa”, tal y como se usa aqti, se refiere a una enzima que actua sobre el carotenoide licopeno-todo-trans que posee grupos psi-terminales en ambos extremos, en un primer paso lo convierte en 5-caroteno; y luego en £-caroteno."Lycopene epsilon cyclase", as used here, refers to an enzyme that acts on the lycopene-all-trans carotenoid that has psi-terminal groups at both ends, in a first step it becomes 5-carotene; and then in £ -carotene.
“ARNi” o ARN de interferencia”, tal y como se usa en la presente invencion, se refiere a moleculas de ARN capaces de silenciar la expresion de un gen. Para ese fin, ARNi son tipicamente oligonucleotidos de doble cadena que tienen al menos 30 pares de bases de longitud, y mas preferiblemente comprenden aproximadamente 25, 24, 23, 22, 21,20, 19, 18 o 17 pares de bases de acidos ribonucleicos. El ARNi de la licopeno epsilon ciclasa tiene la secuencia mostrada en SEQ ID NO: 16."RNAi" or interfering RNA ", as used in the present invention, refers to RNA molecules capable of silencing the expression of a gene. To that end, RNAi are typically double stranded oligonucleotides that are at least 30 base pairs in length, and more preferably comprise about 25, 24, 23, 22, 21,20, 19, 18 or 17 base pairs of ribonucleic acids . The siRNA of lycopene epsilon cyclase has the sequence shown in SEQ ID NO: 16.
“Cruzamiento”, tal y como se usa en la presente invencion, se refiere a la reproduction sexual de dos plantas, dando como resultado una descendencia que hereda parte del material genetico de cada progenitor. Los organismos parientes deben ser geneticamente compatibles y pueden ser de variedades diferentes o de especies muy cercanas. El cruzamiento originalmente se da bajo polinizacion cruzada natural entre plantas cuya constitution genetica es diferente."Crossing," as used in the present invention, refers to the sexual reproduction of two plants, resulting in offspring inheriting part of the genetic material of each parent. Relative organisms must be genetically compatible and can be of different varieties or of very close species. The crossing originally occurs under natural cross pollination between plants whose genetic constitution is different.
55
1010
15fifteen
20twenty
2525
3030
“Linea de maiz con alto nivel de aceite”, tal y como se usa aqw, se refiere a una planta de maiz que presenta en sus granos mayor cantidad de aceite al compararlo con una variedad de maiz silvestre, preferiblemente al menos mas de 6% al compararlo con una variedad silvestre que generalmente presenta entre un 3,5 y 5% de aceite."Corn line with high oil level", as used here, refers to a corn plant that presents in its grains a greater amount of oil when compared to a variety of wild corn, preferably at least more than 6% when compared with a wild variety that generally has between 3.5 and 5% oil.
“NSL30876”, tambien conocida como R78, es una linea de maiz transgenica con alto nivel de aceite.“NSL30876”, also known as R78, is a line of transgenic corn with a high level of oil.
“Codones adecuados para su expresion en plantas”, tal y como se usa se refiere al uso de una secuencia de nucleotidos adecuada para que tras la transcription y traduction no se vea alterada la secuencia de aminoacidos de la protema resultante, como consecuencia de la preferencia de uso de codones."Codons suitable for expression in plants", as used refers to the use of a suitable nucleotide sequence so that after transcription and translation the amino acid sequence of the resulting protein is not altered, as a consequence of the preference of codon usage.
“region 5'UTR”', segun se emplea en la invention se conoce a la region no traducida en position 5'tambien conocida como region lider, se refiere a la region de ARNm que esta inmediatamente anterior al codon de initiation. Dicha region no es traducida, sino que forma una estructura secundaria para regular la traduccion."Region 5'UTR", as used in the invention, the region not translated into position 5'also known as the leading region is known, refers to the region of mRNA that is immediately prior to the initiation codon. This region is not translated, but forms a secondary structure to regulate the translation.
“Alcohol deshidrogenasa”, segun la invencion es un enzima que facilita la interconversion entre alcoholes y aldehidos o cetonas con la reduction de NAD+ a NADH. La protema de alcohol dehidrogenasa clase 3 de arroz tiene la secuencia con numero de acceso Q0DWH1 en la base de datos de Uniprot en fecha 16 de septiembre de 2015."Alcohol dehydrogenase", according to the invention is an enzyme that facilitates the interconversion between alcohols and aldehydes or ketones with the reduction of NAD + to NADH. The rice protein class 3 dehydrogenase protein has the sequence with access number Q0DWH1 in the Uniprot database as of September 16, 2015.
“Huevos enriquecidos en antioxidantes”, tal y como se usa en la presente invencion se refiere a aquellos huevos cuyo contenido en antioxidantes, es decir de moleculas capaces de retardar o prevenir la oxidation de otras moleculas, esta incrementado comparado con un nivel de referencia en huevos comunes, procedentes de aves que no han sido alimentadas con un maiz enriquecido en antioxidantes, Por incrementado tal y como se usa en la presente invencion se refiere el nivel es al menos 1,1 veces, 1,5 veces, 5 veces, 10 veces, 20 veces, 30 veces, 40 veces, 50 veces, 60 veces, 70 veces, 80 veces, 90 veces, 100 veces o incluso mas con respecto al valor de referencia en huevos comunes."Eggs enriched in antioxidants", as used in the present invention refers to those eggs whose antioxidant content, that is to say molecules capable of retarding or preventing oxidation of other molecules, is increased compared to a reference level in Common eggs, from birds that have not been fed with a corn enriched in antioxidants, By increased as used in the present invention the level is referred to at least 1.1 times, 1.5 times, 5 times, 10 times, 20 times, 30 times, 40 times, 50 times, 60 times, 70 times, 80 times, 90 times, 100 times or even more with respect to the reference value in common eggs.
55
1010
15fifteen
20twenty
2525
3030
“Ave” tal y como se usa en la presente invention, se refiere al animal vertebrado que presentan las extremidades anteriores modificadas como alas, con el cuerpo recubierto de plumas y un pico corneo sin dientes."Bird" as used in the present invention, refers to the vertebrate animal having the modified forelimbs as wings, with the body covered with feathers and a corneal peak without teeth.
"Ave de corral", incluye aves domesticas criadas por el hombre para la obtencion de huevos, carne y/o plumas. Los ejemplos de las aves de corral incluyen gallos, gallinas, pavos, patos, gansos, codornices, faisanes, palomas, palomas, emues, avestruces y nandues."Poultry" includes domestic birds bred by man to obtain eggs, meat and / or feathers. Examples of poultry include roosters, chickens, turkeys, ducks, geese, quails, pheasants, pigeons, pigeons, emues, ostriches and nandues.
“Gallina”, tal y como se usa en la presente invencion, se refiere al animal hembra procedente del genero Gallus gallus domesticus."Hen", as used in the present invention, refers to the female animal from the genus Gallus gallus domesticus.
“Huevo” tal y como se emplea en la presente invencion se refiere a un cuerpo redondeado, de diferente tamano y dureza, que producen las hembras de las aves y que contiene el germen del embrion y las sustancias destinadas a su nutrition durante la incubacion."Egg" as used in the present invention refers to a rounded body, of different size and hardness, produced by the females of the birds and containing the germ of the embryo and the substances intended for nutrition during incubation.
“Ovoproductos" tal y como se emplea en la presente invencion se refiere a los productos transformados resultantes de la transformation de huevos, de diversos componentes o mezclas de huevos, o de la transformacion subsiguiente de tales productos transformados. Los ovoproductos pueden clasificarse segun distintos criterios, por sus componentes, por su forma fisica y tratamiento, por su modo de empleo o por la duration de su vida comercial."Egg products" as used in the present invention refers to processed products resulting from the transformation of eggs, various components or mixtures of eggs, or the subsequent transformation of such processed products. Egg products can be classified according to different criteria. , by its components, by its physical form and treatment, by its way of employment or by the duration of its commercial life.
Composiciones de la invencion.Compositions of the invention.
En un primer aspecto, la invencion se relaciona con una composition nutritiva o nutraceutico que comprende una parte de una planta de maiz enriquecida en antioxidantes o un derivado de la misma.In a first aspect, the invention relates to a nutritive or nutraceutical composition comprising a part of a corn plant enriched in antioxidants or a derivative thereof.
La expresion “composicion nutritiva o nutraceutico” se usa en el presente documento en un sentido amplio y cubre alimentos para seres humanos asi como alimentos para animales de production (es decir, un pienso). En un aspecto preferido, la composicionThe expression "nutritive or nutraceutical composition" is used herein in a broad sense and covers food for humans as well as food for production animals (ie, a feed). In a preferred aspect, the composition
55
1010
15fifteen
20twenty
2525
3030
nutritiva o nutraceutico es para consumo animal. La composition nutritiva o nutraceutico puede estar en forma de una disolucion o como un solido, dependiendo del uso y/o el modo de aplicacion y/o el modo de administracion.Nutritious or nutraceutical is for animal consumption. The nutritive or nutraceutical composition may be in the form of a solution or as a solid, depending on the use and / or the mode of application and / or the mode of administration.
Se entiende que una parte de una planta de maiz o un derivado de la misma se encuentra enriquecida en antioxidantes, cuando presenta niveles de antioxidantes superiores a los niveles de una muestra de referencia o muestra control. En particular, se puede considerar que una parte de una planta o derivado de la misma presenta niveles superiores de antioxidantes cuando los niveles son de al menos 1 vez, 1,5 veces, 5 veces, 10 veces, 20 veces, 30 veces, 40 veces, 50 veces, 60 veces, 70 veces, 80 veces, 90 veces, 100 veces o incluso mas con respecto a la muestra de referencia o muestra control. El experto en la materia entendera que no es necesario que una planta enriquecida en antioxidantes contenga niveles elevados de dichos antioxidantes en todos los tejidos de dicha planta, sino que es suficiente con que al menos un tejido de la planta contenga niveles elevados de antioxidantes para que la planta pueda ser considerada como “enriquecida en antioxidantes”. En ese caso, la muestra de referencia para determinar el grado de enriquecimiento en antioxidantes se determina mediante comparacion con los niveles de antioxidantes es una muestra del mismo tejido o parte de una planta control. Por nivel de antioxidantes tambien se engloba el nivel de un solo tipo de antioxidante.It is understood that a part of a corn plant or a derivative thereof is enriched in antioxidants, when it has antioxidant levels higher than the levels of a reference sample or control sample. In particular, a part of a plant or derivative thereof can be considered to have higher levels of antioxidants when the levels are at least 1 time, 1.5 times, 5 times, 10 times, 20 times, 30 times, 40 times, 50 times, 60 times, 70 times, 80 times, 90 times, 100 times or even more with respect to the reference sample or control sample. The person skilled in the art will understand that it is not necessary for an antioxidant-enriched plant to contain high levels of said antioxidants in all tissues of said plant, but it is sufficient that at least one plant tissue contains high levels of antioxidants so that The plant can be considered as "enriched in antioxidants." In that case, the reference sample to determine the degree of antioxidant enrichment is determined by comparison with antioxidant levels is a sample of the same tissue or part of a control plant. The level of a single type of antioxidant is also included by antioxidant level.
Una muestra control o de referencia, tal y como se usa en la presente invention, puede ser el valor que corresponde a los niveles de antioxidantes presentes en una parte de una planta de maiz o derivado de la misma que se encuentra en estado salvaje, es decir no modificada geneticamente.A control or reference sample, as used in the present invention, may be the value that corresponds to the levels of antioxidants present in a part of a corn plant or derived therefrom that is in the wild, it is say not genetically modified.
El experto en la materia conoce diversos metodos para determinar si una planta de maiz o derivado de la misma se encuentra enriquecida en antioxidantes, por ejemplo determinando los niveles de antioxidantes, particularmente carotenoides mediante HPLC (cromatografia liquida de alta resolution) o determinando el incremento de la capacidad antioxidante.The person skilled in the art knows various methods to determine if a corn plant or derivative thereof is enriched in antioxidants, for example by determining antioxidant levels, particularly carotenoids by HPLC (high performance liquid chromatography) or by determining the increase in antioxidant capacity
La capacidad antioxidante puede determinarse mediante la cuantificacion de la capacidad que tienen los compuestos antioxidantes para reaccionar con un radical libre determinado,The antioxidant capacity can be determined by quantifying the ability of antioxidant compounds to react with a given free radical,
55
1010
15fifteen
20twenty
2525
o determinando el potencial que tales compuestos tendrian para reducir el complejo formado entre iones Fe(III) y el reactivo TPTZ (2,4,6-tripiridil-s-triazina).or determining the potential such compounds would have to reduce the complex formed between Fe (III) ions and the TPTZ reagent (2,4,6-tripyridyl-s-triazine).
Entre aquellos ensayos que se basan en la medicion de la capacidad de los antioxidantes para reaccionar con un radical libre, caben destacar los siguientes, ensayo ORAC (del ingles “Oxygen Radical Absorbance Capacity” o capacidad de absorcion de radicales de oxigeno), ensayo TEAC (del ingles Trolox Equivalent Antioxidant Capacity o Capacidad Antioxidante como Equivalentes Trolox) y Ensayo DPPH (2,2-Difenil-1-picrilhidrazil).Among those tests that are based on the measurement of the ability of antioxidants to react with a free radical, the following should be noted: ORAC test ("Oxygen Radical Absorbance Capacity" or oxygen radical absorption capacity), TEAC test (Trolox Equivalent Antioxidant Capacity or Antioxidant Capacity as Trolox Equivalents) and DPPH Test (2,2-Diphenyl-1-picrilhidrazil).
Las composiciones nutritivas o nutraceuticos de la invention comprenden al menos un 0,01 % de la parte de una planta enriquecida en antioxidantes o derivado de la misma, mas preferiblemente al menos un 0,10%, 0,50%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15% 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, o, al menos un 95%.The nutritional or nutraceutical compositions of the invention comprise at least 0.01% of the part of a plant enriched in antioxidants or derived therefrom, more preferably at least 0.10%, 0.50%, 1%, 2 %, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15% 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80 %, 90%, or, at least 95%.
En una realization particular, la composition nutritiva o nutraceutico de la invencion comprende al menos entre un 50 y un 80% de una parte de una planta de maiz enriquecida en antioxidantes o un derivado de la misma.In a particular embodiment, the nutritive or nutraceutical composition of the invention comprises at least 50 to 80% of a part of a corn plant enriched in antioxidants or a derivative thereof.
En otra realizacion mas particular la composicion nutritiva o nutraceutico de la invencion comprende al menos entre un 60 y un 70% de una parte de una planta de maiz enriquecida en antioxidantes o un derivado de la misma, mas particularmente al menos 61, al menos 62, al menos 63, al menos 64, al menos 65, al menos 66, al menos 67, al menos 68, al menos 69.In another more particular embodiment the nutritional or nutraceutical composition of the invention comprises at least 60 to 70% of a part of a corn plant enriched in antioxidants or a derivative thereof, more particularly at least 61, at least 62 , at least 63, at least 64, at least 65, at least 66, at least 67, at least 68, at least 69.
En otra realizacion particular, la parte de la planta de maiz es el endospermo, la semilla o derivados de los mismos. A modo de ejemplo ilustrativo no limitativo, el derivado de la semilla o endospermo puede ser una harina, semola, aceite de maiz, almidon de maiz, fecula de maiz o sirope de maiz entre otros.In another particular embodiment, the part of the corn plant is the endosperm, the seed or derivatives thereof. By way of illustrative, non-limiting example, the derivative of the seed or endosperm can be a flour, semolina, corn oil, corn starch, corn starch or corn syrup among others.
La composicion nutritiva o nutraceutico de acuerdo a la presente invencion se puede preparar directamente a partir de la parte de la planta enriquecida en antioxidantes. En una forma preferida de realizacion, la parte de la planta es el endospermo o granos de maiz, en cuyo caso dicha composicion contiene al menos un 40%, preferiblemente mas de un 50% o mas preferiblemente mas de un 60%.The nutritive or nutraceutical composition according to the present invention can be prepared directly from the part of the plant enriched in antioxidants. In a preferred embodiment, the part of the plant is the endosperm or corn kernels, in which case said composition contains at least 40%, preferably more than 50% or more preferably more than 60%.
55
1010
15fifteen
20twenty
2525
Alternativamente, la parte de la planta que se usa para preparar la composition nutritiva o el nutraceutico de acuerdo a la presente invention puede someterse a una purification parcial para obtener un derivado enriquecido en el producto antioxidante. As^ en el caso de que los compuestos antioxidantes sean carotenoides y que la parte de la planta que se usa sea el endospermo, la composicion nutritiva o el nutraceutico contienen un extracto de granos de maiz o de endospermo que puede encontrarse parcial- o totalmente purificado de forma que el contenido en carotenoides sea superior al que aparece en la parte de la planta de maiz enriquecida. Derivados de maiz que se pueden usar en la presente invencion incluyen harina de maiz, salvado de maiz, aceite de maiz, almidon de maiz, sirope de maiz, y similares.Alternatively, the part of the plant that is used to prepare the nutritive or nutraceutical composition according to the present invention can be subjected to a partial purification to obtain a derivative enriched in the antioxidant product. Thus ^ in the case that the antioxidant compounds are carotenoids and that the part of the plant that is used is the endosperm, the nutritional composition or the nutraceutical contain an extract of corn kernels or endosperm that can be partially- or fully purified so that the carotenoid content is higher than what appears in the part of the enriched corn plant. Corn derivatives that can be used in the present invention include cornmeal, corn bran, corn oil, corn starch, corn syrup, and the like.
Asi, por ejemplo, de acuerdo a la presente invencion, es posible extraer los carotenoides presentes en la parte de las plantas de maiz o derivados de la misma para obtener una composicion nutritiva o nutraceutico.Thus, for example, according to the present invention, it is possible to extract the carotenoids present in the part of the corn plants or derivatives thereof to obtain a nutritive or nutraceutical composition.
El experto en la materia conoce diversos metodos para extraer carotenoides de una parte de una planta de maiz, tal y como extraction a partir de endospermos congelados y HPLC, tal y como se describe en Naqvi S. et al., PNAS 2009, vol. 106, no 19.The person skilled in the art knows various methods for extracting carotenoids from a part of a corn plant, such as extraction from frozen endosperms and HPLC, as described in Naqvi S. et al., PNAS 2009, vol. 106, not 19.
Como entendera un experto en la materia, la composicion nutritiva o nutraceutico de la invencion deben cumplir las normativas y legislation alimentaria del pais.As one skilled in the art will understand, the nutritional or nutraceutical composition of the invention must comply with the regulations and food legislation of the country.
Existen diversos metodos conocidos para la elaboration de composiciones nutritivas y nutraceuticos ampliamente conocidas por el experto en la materia y que pueden emplearse en la presente invencion.There are various known methods for the preparation of nutritional and nutraceutical compositions widely known to those skilled in the art and which can be used in the present invention.
Las composiciones de la invencion o nutraceuticos pueden estar en una forma liquida, semisolida o solida. En una realizacion particular las composiciones o nutraceutico de la invencion se encuentran en forma solida y mas particularmente es un pienso.The compositions of the invention or nutraceuticals may be in a liquid, semi-solid or solid form. In a particular embodiment the compositions or nutraceutical of the invention are in solid form and more particularly it is a feed.
Las composiciones nutritivas o nutraceuticos de la invencion pueden formularse con los excipientes y adyuvantes usuales para las composiciones orales o suplementos alimentarios, como por ejemplo y sin sentido limitativo, componentes grasos, componentes acuosos, humectantes, conservantes, agentes texturizantes, sabores, aromas, antioxidantes y colorantes comunes en el sector alimentario.The nutritive or nutraceutical compositions of the invention can be formulated with the usual excipients and adjuvants for oral compositions or food supplements, such as and without limitation, fatty components, aqueous components, humectants, preservatives, texturizing agents, flavors, aromas, antioxidants and common dyes in the food sector.
55
1010
15fifteen
20twenty
2525
3030
Las necesidades nutritivas de los animales son bien conocidas en el estado de la tecnica. Por ejemplo, las necesidades nutritivas de las aves de corral son descritas en Gail Damerow The Chicken Encyclopedia: An Illustrated Reference. Storey Publishing. pp. 118-119, 135-136 y en el libro Animal Nutrition handbook, seccion 12 paginas 316-331.The nutritional needs of animals are well known in the state of the art. For example, the nutritional needs of poultry are described in Gail Damerow The Chicken Encyclopedia: An Illustrated Reference. Storey Publishing. pp. 118-119, 135-136 and in the book Animal Nutrition handbook, section 12 pages 316-331.
Composiciones nutritivas utiles para la alimentation de aves de corral, y en concreto de engorde para pollos de carne o broilers, de cria de pollitas (semanas 0 a 8), de recria para pollitas (semana 9 -20) o puesta a partir de la semana 21a son conocidas en el estado de la tecnica, por ejemplo en ES2051706T3.Nutritive compositions useful for poultry feed, and in particular fattening for broilers, broiler chickens (weeks 0 to 8), chick rearing (week 9 -20) or starting from week 21a are known in the state of the art, for example in ES2051706T3.
En una forma preferida, los antioxidantes enriquecidos en una planta de maiz son carotenoides.In a preferred form, the antioxidants enriched in a corn plant are carotenoids.
En otra realization particular de la composicion nutritiva o nutraceutico de la invention, la parte de una planta de maiz o un derivado de la misma esta enriquecida en carotenoides que se seleccionan del grupo formado por p-caroteno, Y-caroteno, a-caroteno, a- criptoxantina, p-criptoxantina, licopeno, lutema, zeaxantina y combinaciones de los mismos (composicion nutritiva A o nutraceutico A).In another particular embodiment of the nutritional or nutraceutical composition of the invention, the part of a corn plant or a derivative thereof is enriched in carotenoids that are selected from the group consisting of p-carotene, Y-carotene, a-carotene, acryptoxanthine, p-cryptoxanthin, lycopene, lutema, zeaxanthin and combinations thereof (nutritional composition A or nutraceutical A).
En una realizacion particular de la composicion nutritiva A o nutraceutico A, la planta de maiz o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en uno solo de los carotenoides seleccionado del grupo formado por p-caroteno, Y-caroteno, a-caroteno, a-criptoxantina, p-criptoxantina, licopeno, lutema y zeaxantina.In a particular embodiment of the nutritional composition A or nutraceutical A, the corn plant or derivative thereof enriched in carotenoids is enriched in only one of the carotenoids selected from the group consisting of p-carotene, Y-carotene, a-carotene , a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin.
En una realizacion particular de la composicion nutritiva A o nutraceutico A de la invencion, la planta de maiz o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en al menos 2 carotenoides, a modo ilustrativo se encuentra enriquecida en p-caroteno y y caroteno; p-caroteno y a-caroteno; p-caroteno y a- criptoxantina; p-caroteno y p-criptoxantina;p-caroteno y licopeno; p-caroteno y lutema; p- caroteno y zeaxantina; Y-caroteno y a-caroteno; Y-caroteno y a-criptoxantina; Y-caroteno y p-criptoxantina; Y-caroteno y licopeno; Y-caroteno y lutema; Y-caroteno y zeaxantina; a- caroteno y a-criptoxantina; a-caroteno y p-criptoxantina; a-caroteno y licopeno; a-caroteno y lutema; a-caroteno y zeaxantina; a-criptoxantina y p-criptoxantina; a-criptoxantina y licopeno; a-criptoxantina y lutema; a-criptoxantina y zeaxantina; p-criptoxantina y licopeno;In a particular embodiment of the nutritive composition A or nutraceutical A of the invention, the corn plant or derivative thereof enriched in carotenoids is enriched in at least 2 carotenoids, by way of illustration it is enriched in p-carotene and and carotene; p-carotene and a-carotene; p-carotene and acryptoxanthin; p-carotene and p-cryptoxanthin; p-carotene and lycopene; p-carotene and lutema; p-carotene and zeaxanthin; Y-carotene and a-carotene; Y-carotene and a-cryptoxanthin; Y-carotene and p-cryptoxanthin; Y-carotene and lycopene; Y-carotene and lutema; Y-carotene and zeaxanthin; a-carotene and a-cryptoxanthin; a-carotene and p-cryptoxanthin; a-carotene and lycopene; a-carotene and lutema; a-carotene and zeaxanthin; a-cryptoxanthin and p-cryptoxanthin; a-cryptoxanthin and lycopene; a-cryptoxanthin and lutema; a-cryptoxanthin and zeaxanthin; p-cryptoxanthin and lycopene;
55
1010
15fifteen
20twenty
2525
3030
p-criptoxantina y lutema; p-criptoxantina y zeaxantina; licopeno y lutema; licopeno y zeaxantina; o en lutema y zeaxantina.p-cryptoxanthin and lutema; p-cryptoxanthin and zeaxanthin; lycopene and lutema; lycopene and zeaxanthin; or in lutema and zeaxanthin.
En otra realization de la composition nutritiva A o nutraceutico A de la invention, la planta de ma^z o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en al menos 3 carotenoides, a modo ilustrativo se encuentra enriquecido en p-caroteno, y- caroteno y a-caroteno; p-caroteno,Y-caroteno y a-criptoxantina; p-caroteno,Y-caroteno y p- criptoxantina; p-caroteno,Y-caroteno y licopeno; p-caroteno,Y-caroteno y lutema; p- caroteno,Y-caroteno y zeaxantina; p-caroteno,a-caroteno y a-criptoxantina; p-caroteno,a- caroteno y p-criptoxantina; p-caroteno,a-caroteno y licopeno; p-caroteno,a-caroteno y lutema; p-caroteno,a-caroteno y zeaxantina; p-caroteno,a-criptoxantina y p-criptoxantina; p-caroteno,a-criptoxantina y licopeno; p-caroteno,a-criptoxantina y lutema; p-caroteno,a- criptoxantina y zeaxantina; p-caroteno,p-criptoxantina y licopeno; p-caroteno,p- criptoxantina y lutema; p-caroteno,p-criptoxantina y zeaxantina; p-caroteno,licopeno y lutema; p-caroteno,licopeno y zeaxantina; p-caroteno,lutema y zeaxantina; Y-caroteno,a- caroteno y a-criptoxantina; Y-caroteno,a-caroteno y p-criptoxantina; Y-caroteno,a-caroteno y licopeno; Y-caroteno,a-caroteno y lutema; Y-caroteno,a-caroteno y zeaxantina; y- caroteno,a-criptoxantina y p-criptoxantina; Y-caroteno,a-criptoxantina y licopeno; y- caroteno,a-criptoxantina y lutema; Y-caroteno,a-criptoxantina y zeaxantina; Y-caroteno,p- criptoxantina y licopeno; Y-caroteno,p-criptoxantina y lutema; Y-caroteno,p-criptoxantina y zeaxantina; Y-caroteno,licopeno y lutema; Y-caroteno,licopeno y zeaxantina; y- caroteno,lutema y zeaxantina; a-caroteno,a-criptoxantina y p-criptoxantina; a-caroteno,a- criptoxantina y licopeno; a-caroteno,a-criptoxantina y lutema; a-caroteno,a-criptoxantina y zeaxantina; a-caroteno,p-criptoxantina y licopeno; a-caroteno,p-criptoxantina y lutema; a- caroteno,p-criptoxantina y zeaxantina; a-caroteno,licopeno y lutema; a-caroteno,licopeno y zeaxantina; a-caroteno,lutema y zeaxantina; a-criptoxantina,p-criptoxantina y licopeno; a-criptoxantina,p-criptoxantina y lutema; a-criptoxantina,p-criptoxantina y zeaxantina; a- criptoxantina,licopeno y lutema; a-criptoxantina,licopeno y zeaxantina; a-In another embodiment of the nutritive composition A or nutraceutical A of the invention, the maize plant derived from it enriched in carotenoids is enriched in at least 3 carotenoids, by way of illustration it is enriched in p-carotene, and- carotene and a-carotene; p-carotene, Y-carotene and a-cryptoxanthin; p-carotene, Y-carotene and p-cryptoxanthin; p-carotene, Y-carotene and lycopene; p-carotene, Y-carotene and lutema; p-carotene, Y-carotene and zeaxanthin; p-carotene, a-carotene and a-cryptoxanthin; p-carotene, a-carotene and p-cryptoxanthin; p-carotene, a-carotene and lycopene; p-carotene, a-carotene and lutema; p-carotene, a-carotene and zeaxanthin; p-carotene, a-cryptoxanthin and p-cryptoxanthin; p-carotene, a-cryptoxanthin and lycopene; p-carotene, a-cryptoxanthin and lutema; p-carotene, acryptoxanthin and zeaxanthin; p-carotene, p-cryptoxanthin and lycopene; p-carotene, p-cryptoxanthin and lutema; p-carotene, p-cryptoxanthin and zeaxanthin; p-carotene, lycopene and lutema; p-carotene, lycopene and zeaxanthin; p-carotene, lutema and zeaxanthin; Y-carotene, a-carotene and a-cryptoxanthin; Y-carotene, a-carotene and p-cryptoxanthin; Y-carotene, a-carotene and lycopene; Y-carotene, a-carotene and lutema; Y-carotene, a-carotene and zeaxanthin; and carotene, a-cryptoxanthin and p-cryptoxanthin; Y-carotene, a-cryptoxanthin and lycopene; and carotene, a-cryptoxanthin and lutema; Y-carotene, a-cryptoxanthin and zeaxanthin; Y-carotene, p-cryptoxanthin and lycopene; Y-carotene, p-cryptoxanthin and lutema; Y-carotene, p-cryptoxanthin and zeaxanthin; Y-carotene, lycopene and lutema; Y-carotene, lycopene and zeaxanthin; y- carotene, lutema and zeaxanthin; a-carotene, a-cryptoxanthin and p-cryptoxanthin; a-carotene, acryptoxanthine and lycopene; a-carotene, a-cryptoxanthin and lutema; a-carotene, a-cryptoxanthin and zeaxanthin; a-carotene, p-cryptoxanthin and lycopene; a-carotene, p-cryptoxanthin and lutema; a-carotene, p-cryptoxanthin and zeaxanthin; a-carotene, lycopene and lutema; a-carotene, lycopene and zeaxanthin; a-carotene, lutema and zeaxanthin; a-cryptoxanthin, p-cryptoxanthin and lycopene; a-cryptoxanthin, p-cryptoxanthin and lutema; a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; acryptoxanthin, lycopene and lutema; a-cryptoxanthin, lycopene and zeaxanthin; to-
criptoxantina,lutema y zeaxantina; p-criptoxantina,licopeno y lutema; p- criptoxantina,licopeno y zeaxantina; p-criptoxantina,lutema y zeaxantina o enriquecido en licopeno,lutema y zeaxantina.cryptoxanthin, lutema and zeaxanthin; p-cryptoxanthin, lycopene and lutema; p-cryptoxanthin, lycopene and zeaxanthin; p-cryptoxanthin, lutema and zeaxanthin or enriched in lycopene, lutema and zeaxanthin.
55
1010
15fifteen
20twenty
2525
3030
En otra realization de la composition nutritiva A o nutraceutico A de la invention, la planta de ma^z enriquecida o derivado de la misma en carotenoides se encuentra enriquecida en al menos 4 carotenoides, a modo ilustrativo se encuentra enriquecido en p-caroteno,Y- caroteno,a-caroteno y a-criptoxantina; p-caroteno,Y-caroteno,a-caroteno y p-criptoxantina; P-caroteno,Y-caroteno,a-caroteno y licopeno; p-caroteno,Y-caroteno,a-caroteno y lutema; P-caroteno,Y-caroteno,a-caroteno y zeaxantina; p-caroteno,Y-caroteno,a-criptoxantina y p- criptoxantina; p-caroteno,Y-caroteno,a-criptoxantina y licopeno; p-caroteno,Y-caroteno,a- criptoxantina y lutema; p-caroteno,Y-caroteno,a-criptoxantina y zeaxantina; p-caroteno,Y- caroteno,p-criptoxantina y licopeno; p-caroteno,Y-caroteno,p-criptoxantina y lutema; p- caroteno,Y-caroteno,p-criptoxantina y zeaxantina; p-caroteno,Y-caroteno,licopeno y lutema; p-caroteno,Y-caroteno,licopeno y zeaxantina; p-caroteno,Y-caroteno,lutema y zeaxantina; p-caroteno,a-caroteno,a-criptoxantina y p-criptoxantina; p-caroteno,a- caroteno,a-criptoxantina y licopeno; p-caroteno,a-caroteno,a-criptoxantina y lutema; p- caroteno,a-caroteno,a-criptoxantina y zeaxantina; p-caroteno,a-caroteno,p-criptoxantina y licopeno; p-caroteno,a-caroteno,p-criptoxantina y lutema; p-caroteno,a-caroteno,p- criptoxantina y zeaxantina; p-caroteno,a-caroteno,licopeno y lutema; p-caroteno,a- caroteno,licopeno y zeaxantina; p-caroteno,a-caroteno,lutema y zeaxantina; p-caroteno,a- criptoxantina,p-criptoxantina y licopeno; p-caroteno,a-criptoxantina,p-criptoxantina y lutema; p-caroteno,a-criptoxantina,p-criptoxantina y zeaxantina; p-caroteno,a-In another embodiment of the nutritive composition A or nutraceutical A of the invention, the maize plant enriched or derived from it in carotenoids is enriched in at least 4 carotenoids, by way of illustration it is enriched in p-carotene, Y - carotene, a-carotene and a-cryptoxanthin; p-carotene, Y-carotene, a-carotene and p-cryptoxanthin; P-carotene, Y-carotene, a-carotene and lycopene; p-carotene, Y-carotene, a-carotene and lutema; P-carotene, Y-carotene, a-carotene and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin and p-cryptoxanthin; p-carotene, Y-carotene, a-cryptoxanthin and lycopene; p-carotene, Y-carotene, acryptoxanthin and lutema; p-carotene, Y-carotene, a-cryptoxanthin and zeaxanthin; p-carotene, Y-carotene, p-cryptoxanthin and lycopene; p-carotene, Y-carotene, p-cryptoxanthin and lutema; p-carotene, Y-carotene, p-cryptoxanthin and zeaxanthin; p-carotene, Y-carotene, lycopene and lutema; p-carotene, Y-carotene, lycopene and zeaxanthin; p-carotene, Y-carotene, lutema and zeaxanthin; p-carotene, a-carotene, a-cryptoxanthin and p-cryptoxanthin; p-carotene, a-carotene, a-cryptoxanthin and lycopene; p-carotene, a-carotene, a-cryptoxanthin and lutema; p-carotene, a-carotene, a-cryptoxanthin and zeaxanthin; p-carotene, a-carotene, p-cryptoxanthin and lycopene; p-carotene, a-carotene, p-cryptoxanthin and lutema; p-carotene, a-carotene, p-cryptoxanthin and zeaxanthin; p-carotene, a-carotene, lycopene and lutema; p-carotene, a-carotene, lycopene and zeaxanthin; p-carotene, a-carotene, lutema and zeaxanthin; p-carotene, acryptoxanthin, p-cryptoxanthin and lycopene; p-carotene, a-cryptoxanthin, p-cryptoxanthin and lutema; p-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; p-carotene, a-
criptoxantina,licopeno y lutema; p-caroteno,a-criptoxantina,licopeno y zeaxantina; p- caroteno,a-criptoxantina,lutema y zeaxantina; p-caroteno,p-criptoxantina,licopeno y lutema; p-caroteno,p-criptoxantina,licopeno y zeaxantina; p-caroteno,p-cryptoxanthin, lycopene and lutema; p-carotene, a-cryptoxanthin, lycopene and zeaxanthin; p-carotene, a-cryptoxanthin, lutema and zeaxanthin; p-carotene, p-cryptoxanthin, lycopene and lutema; p-carotene, p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, p-
criptoxantina,lutema y zeaxantina; p-caroteno,licopeno,lutema y zeaxantina; Y-caroteno,a- caroteno,a-criptoxantina y p-criptoxantina; Y-caroteno,a-caroteno,a-criptoxantina y licopeno; Y-caroteno,a-caroteno,a-criptoxantina y lutema; Y-caroteno,a-caroteno,a- criptoxantina y zeaxantina; Y-caroteno,a-caroteno,p-criptoxantina y licopeno; Y-caroteno,a- caroteno,p-criptoxantina y lutema; Y-caroteno,a-caroteno,p-criptoxantina y zeaxantina; y- caroteno,a-caroteno,licopeno y lutema; Y-caroteno,a-caroteno,licopeno y zeaxantina; y- caroteno,a-caroteno,lutema y zeaxantina; Y-caroteno,a-criptoxantina,p-criptoxantina y licopeno; Y-caroteno,a-criptoxantina,p-criptoxantina y lutema; Y-caroteno,a-criptoxantina,p- criptoxantina y zeaxantina; Y-caroteno,a-criptoxantina,licopeno y lutema; Y-caroteno,a- criptoxantina,licopeno y zeaxantina; Y-caroteno,a-criptoxantina,lutema y zeaxantina; y- caroteno,p-criptoxantina,licopeno y lutema; Y-caroteno,p-criptoxantina,licopeno ycryptoxanthin, lutema and zeaxanthin; p-carotene, lycopene, lutema and zeaxanthin; Y-carotene, a-carotene, a-cryptoxanthin and p-cryptoxanthin; Y-carotene, a-carotene, a-cryptoxanthin and lycopene; Y-carotene, a-carotene, a-cryptoxanthin and lutema; Y-carotene, a-carotene, acryptoxanthine and zeaxanthin; Y-carotene, a-carotene, p-cryptoxanthin and lycopene; Y-carotene, a-carotene, p-cryptoxanthin and lutema; Y-carotene, a-carotene, p-cryptoxanthin and zeaxanthin; and carotene, a-carotene, lycopene and lutema; Y-carotene, a-carotene, lycopene and zeaxanthin; and carotene, a-carotene, lutema and zeaxanthin; Y-carotene, a-cryptoxanthin, p-cryptoxanthin and lycopene; Y-carotene, a-cryptoxanthin, p-cryptoxanthin and lutema; Y-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; Y-carotene, a-cryptoxanthin, lycopene and lutema; Y-carotene, acryptoxanthin, lycopene and zeaxanthin; Y-carotene, a-cryptoxanthin, lutema and zeaxanthin; and carotene, p-cryptoxanthin, lycopene and lutema; Y-carotene, p-cryptoxanthin, lycopene and
55
1010
15fifteen
20twenty
2525
3030
zeaxantina; Y-caroteno,p-criptoxantina,lutema y zeaxantina; Y-caroteno,licopeno,lutema y zeaxantina; a-caroteno,a-criptoxantina,p-criptoxantina y licopeno; a-caroteno,a-zeaxanthin; Y-carotene, p-cryptoxanthin, lutema and zeaxanthin; Y-carotene, lycopene, lutema and zeaxanthin; a-carotene, a-cryptoxanthin, p-cryptoxanthin and lycopene; a-carotene, a-
criptoxantina,p-criptoxantina y lutema; a-caroteno,a-criptoxantina,p-criptoxantina y zeaxantina; a-caroteno,a-criptoxantina,licopeno y lutema; a-caroteno,a-cryptoxanthin, p-cryptoxanthin and lutema; a-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; a-carotene, a-cryptoxanthin, lycopene and lutema; a-carotene, a-
criptoxantina,licopeno y zeaxantina; a-caroteno,a-criptoxantina,lutema y zeaxantina; a- caroteno,p-criptoxantina,licopeno y lutema; a-caroteno,p-criptoxantina,licopeno ycryptoxanthin, lycopene and zeaxanthin; a-carotene, a-cryptoxanthin, lutema and zeaxanthin; a-carotene, p-cryptoxanthin, lycopene and lutema; a-carotene, p-cryptoxanthin, lycopene and
zeaxantina; a-caroteno,p-criptoxantina,lutema y zeaxantina; a-caroteno,licopeno,lutema y zeaxantina; a-criptoxantina,p-criptoxantina,licopeno y lutema; a-criptoxantina,p-zeaxanthin; a-carotene, p-cryptoxanthin, lutema and zeaxanthin; a-carotene, lycopene, lutema and zeaxanthin; a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; a-cryptoxanthin, p-
criptoxantina,licopeno y zeaxantina; a-criptoxantina,p-criptoxantina,lutema y zeaxantina; a-criptoxantina,licopeno,lutema y zeaxantina; o enriquecido encryptoxanthin, lycopene and zeaxanthin; a-cryptoxanthin, p-cryptoxanthin, lutema and zeaxanthin; a-cryptoxanthin, lycopene, lutema and zeaxanthin; or enriched in
criptoxantina,licopeno,lutema y zeaxantina.cryptoxanthin, lycopene, lutema and zeaxanthin.
En otra realization de la composition nutritiva A o nutraceutico A de la invention, la planta de ma^z o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en al menos 5 carotenoides, a modo ilustrativo se encuentra enriquecido en p-caroteno,Y- caroteno,a-caroteno,a-criptoxantina y p-criptoxantina; p-caroteno,Y-caroteno,a-caroteno,a- criptoxantina y licopeno; p-caroteno,Y-caroteno,a-caroteno,a-criptoxantina y lutema; p- caroteno,Y-caroteno,a-caroteno,a-criptoxantina y zeaxantina; p-caroteno,Y-caroteno,a- caroteno,p-criptoxantina y licopeno; p-caroteno,Y-caroteno,a-caroteno,p-criptoxantina y lutema; p-caroteno,Y-caroteno,a-caroteno,p-criptoxantina y zeaxantina; p-caroteno,Y- caroteno,a-caroteno,licopeno y lutema; p-caroteno,Y-caroteno,a-caroteno,licopeno y zeaxantina; p-caroteno,Y-caroteno,a-caroteno,lutema y zeaxantina; p-caroteno,Y- caroteno,a-criptoxantina,p-criptoxantina y licopeno; p-caroteno,Y-caroteno,a- criptoxantina,p-criptoxantina y lutema; p-caroteno,Y-caroteno,a-criptoxantina,p- criptoxantina y zeaxantina; p-caroteno,Y-caroteno,a-criptoxantina,licopeno y lutema; p- caroteno,Y-caroteno,a-criptoxantina,licopeno y zeaxantina; p-caroteno,Y-caroteno,a- criptoxantina,lutema y zeaxantina; p-caroteno,Y-caroteno,p-criptoxantina,licopeno y lutema; p-caroteno,Y-caroteno,p-criptoxantina,licopeno y zeaxantina; p-caroteno,Y- caroteno,p-criptoxantina,lutema y zeaxantina; p-caroteno,Y-caroteno,licopeno,lutema y zeaxantina; p-caroteno,a-caroteno,a-criptoxantina,p-criptoxantina y licopeno; p- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina y lutema; p-caroteno,a-caroteno,a- criptoxantina,p-criptoxantina y zeaxantina; p-caroteno,a-caroteno,a-criptoxantina,licopeno y lutema; p-caroteno,a-caroteno,a-criptoxantina,licopeno y zeaxantina; p-caroteno,a-In another embodiment of the nutritive composition A or nutraceutical A of the invention, the maize plant derived from it enriched in carotenoids is enriched in at least 5 carotenoids, by way of illustration it is enriched in p-carotene, Y- carotene, a-carotene, a-cryptoxanthin and p-cryptoxanthin; p-carotene, Y-carotene, a-carotene, acryptoxanthin and lycopene; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin and lutema; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin and zeaxanthin; p-carotene, Y-carotene, a-carotene, p-cryptoxanthin and lycopene; p-carotene, Y-carotene, a-carotene, p-cryptoxanthin and lutema; p-carotene, Y-carotene, a-carotene, p-cryptoxanthin and zeaxanthin; p-carotene, Y-carotene, a-carotene, lycopene and lutema; p-carotene, Y-carotene, a-carotene, lycopene and zeaxanthin; p-carotene, Y-carotene, a-carotene, lutema and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin, p-cryptoxanthin and lycopene; p-carotene, Y-carotene, acryptoxanthin, p-cryptoxanthin and lutema; p-carotene, Y-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin, lycopene and lutema; p-carotene, Y-carotene, a-cryptoxanthin, lycopene and zeaxanthin; p-carotene, Y-carotene, acryptoxanthin, lutema and zeaxanthin; p-carotene, Y-carotene, p-cryptoxanthin, lycopene and lutema; p-carotene, Y-carotene, p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, Y-carotene, p-cryptoxanthin, lutema and zeaxanthin; p-carotene, Y-carotene, lycopene, lutema and zeaxanthin; p-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and lycopene; p-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and lutema; p-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; p-carotene, a-carotene, a-cryptoxanthin, lycopene and lutema; p-carotene, a-carotene, a-cryptoxanthin, lycopene and zeaxanthin; p-carotene, a-
55
1010
15fifteen
20twenty
2525
3030
caroteno,a-criptoxantina,lutema y zeaxantina; p-caroteno,a-caroteno,p-carotene, a-cryptoxanthin, lutema and zeaxanthin; p-carotene, a-carotene, p-
criptoxantina,licopeno y lutema; p-caroteno,a-caroteno,p-criptoxantina,licopeno ycryptoxanthin, lycopene and lutema; p-carotene, a-carotene, p-cryptoxanthin, lycopene and
zeaxantina; p-caroteno,a-caroteno,p-criptoxantina,lutema y zeaxantina; p-caroteno,a- caroteno,licopeno,lutema y zeaxantina; |3-caroteno,a-criptoxantina,p-criptoxantina,licopeno y lutema; p-caroteno,a-criptoxantina,p-criptoxantina,licopeno y zeaxantina; p-caroteno,a- criptoxantina,p-criptoxantina,lutema y zeaxantina; p-caroteno,a-zeaxanthin; p-carotene, a-carotene, p-cryptoxanthin, lutema and zeaxanthin; p-carotene, a-carotene, lycopene, lutema and zeaxanthin; 3-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; p-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, acryptoxanthin, p-cryptoxanthin, lutema and zeaxanthin; p-carotene, a-
criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,p-criptoxantina,licopeno,lutema y zeaxantina; Y-caroteno,a-caroteno,a-criptoxantina,p-criptoxantina y licopeno; Y-caroteno,a- caroteno,a-criptoxantina,p-criptoxantina y lutema; Y-caroteno,a-caroteno,a-criptoxantina,p- criptoxantina y zeaxantina; Y-caroteno,a-caroteno,a-criptoxantina,licopeno y lutema; y- caroteno,a-caroteno,a-criptoxantina,licopeno y zeaxantina; Y-caroteno,a-caroteno,a- criptoxantina,lutema y zeaxantina; Y-caroteno,a-caroteno,p-criptoxantina,licopeno y lutema; Y-caroteno,a-caroteno,p-criptoxantina,licopeno y zeaxantina; Y-caroteno,a- caroteno,p-criptoxantina,lutema y zeaxantina; Y-caroteno,a-caroteno,licopeno,lutema y zeaxantina; Y-caroteno,a-criptoxantina,p-criptoxantina,licopeno y lutema; Y-caroteno,a- criptoxantina,p-criptoxantina,licopeno y zeaxantina; Y-caroteno,a-criptoxantina,p- criptoxantina,lutema y zeaxantina; Y-caroteno,a-criptoxantina,licopeno,lutema ycryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, p-cryptoxanthin, lycopene, lutema and zeaxanthin; Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and lycopene; Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and lutema; Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; Y-carotene, a-carotene, a-cryptoxanthin, lycopene and lutema; and carotene, a-carotene, a-cryptoxanthin, lycopene and zeaxanthin; Y-carotene, a-carotene, acryptoxanthin, lutema and zeaxanthin; Y-carotene, a-carotene, p-cryptoxanthin, lycopene and lutema; Y-carotene, a-carotene, p-cryptoxanthin, lycopene and zeaxanthin; Y-carotene, a-carotene, p-cryptoxanthin, lutema and zeaxanthin; Y-carotene, a-carotene, lycopene, lutema and zeaxanthin; Y-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; Y-carotene, acryptoxanthin, p-cryptoxanthin, lycopene and zeaxanthin; Y-carotene, a-cryptoxanthin, p-cryptoxanthin, lutema and zeaxanthin; Y-carotene, a-cryptoxanthin, lycopene, lutema and
zeaxantina; Y-caroteno,p-criptoxantina,licopeno,lutema y zeaxantina; a-caroteno,a- criptoxantina,p-criptoxantina,licopeno y lutema; a-caroteno,a-criptoxantina,p-zeaxanthin; Y-carotene, p-cryptoxanthin, lycopene, lutema and zeaxanthin; a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; a-carotene, a-cryptoxanthin, p-
criptoxantina,licopeno y zeaxantina; a-caroteno,a-criptoxantina,p-criptoxantina,lutema y zeaxantina; a-caroteno,a-criptoxantina,licopeno,lutema y zeaxantina; a-caroteno,p- criptoxantina,licopeno,lutema y zeaxantina o enriquecido en a-criptoxantina,p- criptoxantina,licopeno,lutema y zeaxantina.cryptoxanthin, lycopene and zeaxanthin; a-carotene, a-cryptoxanthin, p-cryptoxanthin, lutema and zeaxanthin; a-carotene, a-cryptoxanthin, lycopene, lutema and zeaxanthin; a-carotene, p-cryptoxanthin, lycopene, lutema and zeaxanthin or enriched in a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin.
En otra realization de la composition nutritiva A o nutraceutico A de la invention, la planta de ma^z o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en al menos 6 carotenoides, a modo ilustrativo se encuentra enriquecido en p-caroteno,Y- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina y licopeno; p-caroteno,Y-caroteno,a- caroteno,a-criptoxantina,p-criptoxantina y lutema; p-caroteno,Y-caroteno,a-caroteno,a- criptoxantina,p-criptoxantina y zeaxantina; p-caroteno,Y-caroteno,a-caroteno,a- criptoxantina,licopeno y lutema; p-caroteno,Y-caroteno,a-caroteno,a-criptoxantina,licopeno y zeaxantina; p-caroteno,Y-caroteno,a-caroteno,a-criptoxantina,lutema y zeaxantina, p- caroteno,Y-caroteno,a-caroteno,p-criptoxantina,licopeno y lutema; p-caroteno,Y-In another embodiment of the nutritive composition A or nutraceutical A of the invention, the maize plant derived from it enriched in carotenoids is enriched in at least 6 carotenoids, by way of illustration it is enriched in p-carotene, Y- carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and lycopene; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and lutema; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin and zeaxanthin; p-carotene, Y-carotene, a-carotene, acryptoxanthin, lycopene and lutema; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, lycopene and zeaxanthin; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, lutema and zeaxanthin, p-carotene, Y-carotene, a-carotene, p-cryptoxanthin, lycopene and lutema; p-carotene, Y-
55
1010
15fifteen
20twenty
2525
3030
caroteno,a-caroteno,p-criptoxantina,licopeno y zeaxantina; p-caroteno,Y-caroteno,a- caroteno,p-criptoxantina,lutema y zeaxantina; p-caroteno,Y-caroteno,a-carotene, a-carotene, p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, Y-carotene, a-carotene, p-cryptoxanthin, lutema and zeaxanthin; p-carotene, Y-carotene, a-
caroteno,licopeno,lutema y zeaxantina; p-caroteno,Y-caroteno,a-criptoxantina,p- criptoxantina,licopeno y lutema; p-caroteno,Y-caroteno,a-criptoxantina,p-carotene, lycopene, lutema and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; p-carotene, Y-carotene, a-cryptoxanthin, p-
criptoxantina,licopeno y zeaxantina; p-caroteno,Y-caroteno,a-criptoxantina,p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin, p-
criptoxantina,lutema y zeaxantina; p-caroteno,Y-caroteno,a-criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,Y-caroteno,p-criptoxantina,licopeno,lutema y zeaxantina; p- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina,licopeno y lutema; p-caroteno,a- caroteno,a-criptoxantina,p-criptoxantina,licopeno y zeaxantina; p-caroteno,a-caroteno,a- criptoxantina,p-criptoxantina,lutema y zeaxantina; p-caroteno,a-caroteno,a-cryptoxanthin, lutema and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, Y-carotene, p-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; p-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, a-carotene, acryptoxanthin, p-cryptoxanthin, lutema and zeaxanthin; p-carotene, a-carotene, a-
criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,a-caroteno,p-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, a-carotene, p-
criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,a-criptoxantina,p-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, a-cryptoxanthin, p-
criptoxantina,licopeno,lutema y zeaxantina; Y-caroteno,a-caroteno,a-criptoxantina,p- criptoxantina,licopeno y lutema; Y-caroteno,a-caroteno,a-criptoxantina,p-cryptoxanthin, lycopene, lutema and zeaxanthin; Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; Y-carotene, a-carotene, a-cryptoxanthin, p-
criptoxantina,licopeno y zeaxantina; Y-caroteno,a-caroteno,a-criptoxantina,p-cryptoxanthin, lycopene and zeaxanthin; Y-carotene, a-carotene, a-cryptoxanthin, p-
criptoxantina,lutema y zeaxantina; Y-caroteno,a-caroteno,a-criptoxantina,licopeno,lutema y zeaxantina; Y-caroteno,a-caroteno,p-criptoxantina,licopeno,lutema y zeaxantina; y- caroteno,a-criptoxantina,p-criptoxantina,licopeno,lutema y zeaxantina o enriquecido en a- caroteno,a-criptoxantina,p-criptoxantina,licopeno,lutema y zeaxantina.cryptoxanthin, lutema and zeaxanthin; Y-carotene, a-carotene, a-cryptoxanthin, lycopene, lutema and zeaxanthin; Y-carotene, a-carotene, p-cryptoxanthin, lycopene, lutema and zeaxanthin; and carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin or enriched in acarotene, a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin.
En otra realization de la composition nutritiva A o nutraceutico A de la invention, la planta de ma^z o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en al menos 7 carotenoides, a modo ilustrativo se encuentra enriquecido en p-caroteno,Y- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina,licopeno y lutema; p-caroteno,Y- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina,licopeno y zeaxantina; p-caroteno,Y- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina,lutema y zeaxantina; p-caroteno,Y- caroteno,a-caroteno,a-criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,Y- caroteno,a-caroteno,p-criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,Y- caroteno,a-criptoxantina,p-criptoxantina,licopeno,lutema y zeaxantina; p-caroteno,a- caroteno,a-criptoxantina,p-criptoxantina,licopeno,lutema y zeaxantina; o enriquecida en y- caroteno,a-caroteno,a-criptoxantina,p-criptoxantina,licopeno,lutema y zeaxantina.In another embodiment of the nutritive composition A or nutraceutical A of the invention, the maize plant derived from it enriched in carotenoids is enriched in at least 7 carotenoids, by way of illustration it is enriched in p-carotene, Y- carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and lutema; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene and zeaxanthin; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lutema and zeaxanthin; p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, Y-carotene, a-carotene, p-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, Y-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin; p-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin; or enriched in y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema and zeaxanthin.
55
1010
15fifteen
20twenty
2525
3030
En otra realizacion particular de la composicion nutritiva A o nutraceutico A de la invencion, la planta de maiz o derivado de la misma enriquecida en carotenoides se encuentra enriquecida en p-caroteno, Y-caroteno, a-caroteno, a-criptoxantina, p- criptoxantina, licopeno, lutema y zeaxantina.In another particular embodiment of the nutritional composition A or nutraceutical A of the invention, the corn plant or derivative thereof enriched in carotenoids is enriched in p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p- cryptoxanthin, lycopene, lutema and zeaxanthin.
En otra realizacion de la composicion nutritiva A o nutraceutico A de la invencion, la planta de maiz o derivado de la misma enriquecida en antioxidantes es una planta de maiz transgenica que expresa al menos un transgen que codifica una fitoeno sintasa y un transgen que codifica una caroteno desaturasa. Mas particularmente la planta de maiz expresa adicionalmente un transgen seleccionado del grupo formado por un transgen que codifica una licopeno p-ciclasa, un transgen que codifica una p-caroteno hidroxilasa y un transgen que codifica una carotenoide cetolasa.In another embodiment of the nutritional composition A or nutraceutical A of the invention, the corn plant or derivative thereof enriched in antioxidants is a transgenic corn plant that expresses at least one transgene encoding a phytoen synthase and a transgene encoding a carotene desaturase. More particularly, the corn plant further expresses a transgene selected from the group consisting of a transgene encoding a lycopene p-cyclase, a transgene encoding a p-carotene hydroxylase and a transgene encoding a carotenoid ketolase.
En otra realizacion particular, las secuencias de los transgenes tienen adaptados los codones para su expresion en plantas.In another particular embodiment, the sequences of the transgenes have codons adapted for expression in plants.
Un experto en la materia puede conocer y determinar la secuencia de los transgenes anteriormente citados.A person skilled in the art can know and determine the sequence of the aforementioned transgenes.
En otra realizacion mas particular el transgen que codifica la fitoeno sintasa procede de Zea mays y tiene la secuencia mostrada en SEQ ID NO: 1, el transgen que codifica la caroteno desaturasa procede de Erwinia eurodevora y tiene la secuencia mostrada en SEQ ID NO: 2, el transgen que codifica la licopeno p-ciclasa procede de Gentiana lutea y tiene la secuencia mostrada en SEQ ID NO:3, el transgen que codifica la p-caroteno hidroxilasa procede de Zea mays y tiene la secuencia mostrada en SEQ ID NO:4 o procede de Gentiana lutea y tiene la secuencia mostrada en SEQ ID NO:6 y el transgen que codifica la carotenoide cetolasa procede de Paracoccus sp. tiene la secuencia mostrada en SEQ ID NO:7.In another more particular embodiment, the transgene encoding the phytoeno synthase comes from Zea mays and has the sequence shown in SEQ ID NO: 1, the transgene encoding the carotene desaturase comes from Erwinia eurodevora and has the sequence shown in SEQ ID NO: 2 , the transgene encoding lycopene p-cyclase comes from Gentiana lutea and has the sequence shown in SEQ ID NO: 3, the transgene encoding p-carotene hydroxylase comes from Zea mays and has the sequence shown in SEQ ID NO: 4 or comes from Gentiana lutea and has the sequence shown in SEQ ID NO: 6 and the transgene encoding the carotenoid ketolase comes from Paracoccus sp. It has the sequence shown in SEQ ID NO: 7.
En una realizacion particular, la planta de maiz es maiz blanco o maiz amarillo. Maiz blanco se refiere a una variedad de maiz en el que el endospermo tiene color blanco, como consecuencia de la ausencia de los pigmentos carotenoides que confieren el color amarillo al endospermo del maiz conocido como maiz amarillo.In a particular embodiment, the corn plant is white corn or yellow corn. White corn refers to a variety of corn in which the endosperm has a white color, as a result of the absence of carotenoid pigments that confer yellow color to the endosperm of the corn known as yellow corn.
55
1010
15fifteen
20twenty
2525
3030
Un experto en la materia conoce las tecnicas adecuadas para la generacion de plantas transgenicas. Para una revision de la transferencia genica a plantas, incluyendo vectores, metodos de transferencia de ADN, etc, vease, por ejemplo, Twyman RM,2004, Handbook of Plant Biotechnology. John Wiley & Sons Inc., NY, pp 263-289, o Komari et al., 2004 Handbook of Plant Biotechnology. John Wiley & Sons Inc., NY, pp 233-262.A person skilled in the art knows the appropriate techniques for the generation of transgenic plants. For a review of the genetic transfer to plants, including vectors, DNA transfer methods, etc., see, for example, Twyman RM, 2004, Handbook of Plant Biotechnology. John Wiley & Sons Inc., NY, pp 263-289, or Komari et al., 2004 Handbook of Plant Biotechnology. John Wiley & Sons Inc., NY, pp 233-262.
Brevemente dichos metodos pueden incluir: 1) empleo de un vector vivo que lleve el material genetico a la celula blanco mediante virus geneticamente modificados o el mecanismo natural de infeccion de la bacteria del suelo Agrobacterium tumefaciens, 2) El uso de protoplastos, que son celulas vegetales a las que se les ha liberado de la pared celular, o 3) la biolistica que consiste en bombardear las celulas con particulas metalicas microscopicas recubiertas del ADN que se desea introducir.Briefly, said methods may include: 1) use of a live vector that carries the genetic material to the white cell by means of genetically modified viruses or the natural mechanism of infection of the soil bacterium Agrobacterium tumefaciens, 2) The use of protoplasts, which are cells plants that have been freed from the cell wall, or 3) the biolistic that consists of bombarding the cells with microscopic metallic particles coated with the DNA that you want to introduce.
En concreto, para la generacion de plantas de maiz transgenico se ha propuesto la introduction de ADN en celulas de maiz incluyendo la electroporation, microinyeccion, bombardeo con microproyectiles, fusion de liposomas, transferencia mediada por Agrobacterium, macroinyeccion y la exposition a ADN desnudo en solution.Specifically, for the generation of transgenic corn plants, the introduction of DNA into corn cells has been proposed including electroporation, microinjection, microprojectile bombardment, liposome fusion, Agrobacterium-mediated transfer, macroinjection and exposure to naked DNA in solution. .
Para lograr que el gen contenido en la molecula de ADN recombinante se exprese en los niveles y en los tejidos adecuados, es deseable, pero no necesario para genes de origen vegetal, que este contenido en un casette de expresion que incluya una secuencia promotora de la transcription funcional en plantas, la parte codificante del gen de interes y un terminador de la transcripcion funcional en plantas. Adicionalmente se puede incluir una secuencia que codifique para un peptido de transito que dirija la enzima a un compartimiento espetifico de la celula. El peptido de transito y las senales de procesamiento correspondientes pueden ser derivados de cualquier protema vegetal que se sintetiza en el citoplasma y es translocada al compartimiento subcelular de interes, ya sea el plastido o la mitocondria. Por ejemplo, para localizar en los plastidos pueden ser usadas secuencias derivadas de genes que codifican para la subunidad pequena de la ribulosa bisfosfato carboxilasa o las protemas CAB que son aquellas que se unen a las clorofilas a y b para formal las antenas cosechadoras de luz (Van den Broek et al Nature (London) 313, 358-363 (1985)).To ensure that the gene contained in the recombinant DNA molecule is expressed in the appropriate levels and tissues, it is desirable, but not necessary for genes of plant origin, that this content in an expression cassette that includes a promoter sequence of the functional transcription in plants, the coding part of the gene of interest and a terminator of functional transcription in plants. Additionally, a sequence encoding a transit peptide that directs the enzyme to a specific cell compartment can be included. The transit peptide and the corresponding processing signals can be derived from any plant protein that is synthesized in the cytoplasm and translocated to the subcellular compartment of interest, either the plastid or the mitochondria. For example, sequences derived from genes encoding the small subunit of ribulose bisphosphate carboxylase or CAB proteins that are those that bind to chlorophylls a and b for formal light harvesting antennas can be used in plastids (Van den Broek et al Nature (London) 313, 358-363 (1985)).
55
1010
15fifteen
20twenty
2525
3030
Para el caso de genes que no son de origen vegetal, en la secuencia iniciadora de la transcription se debe incluir un promotor y se puede emplear tambien una senal de inicio de la traduction optima para plantas o uno de los llamados potenciadores de la traduction.In the case of genes that are not of plant origin, a promoter must be included in the transcription initiation sequence and an optimal translation initiation signal for plants or one of the so-called translation enhancers can also be used.
Segun la presente invention, si el transgen procede de un organismo que no es de origen vegetal, entonces las protemas codificadas por dicho transgen forman parte de una protema de fusion que comprende en position N con respecto a la protema codificada por dicho gen, una secuencia de direccionamiento de protemas al cloroplasto.According to the present invention, if the transgene comes from an organism that is not of plant origin, then the proteins encoded by said transgene form part of a fusion protein that comprises at position N with respect to the protein encoded by said gene, a sequence of addressing proteins to the chloroplast.
Asi, si el transgen que codifica la caroteno desaturasa tiene la secuencia mostrada en SEQ ID NO: 2, entonces la caroteno desaturasa forma parte de una protema de fusion que comprende en posicion N con respecto a la caroteno desaturasa una secuencia para el direccionamiento de protemas al cloroplasto.Thus, if the transgene encoding the carotene desaturase has the sequence shown in SEQ ID NO: 2, then the carotene desaturase is part of a fusion protein that comprises in position N with respect to the carotene desaturase a sequence for protein targeting to chloroplast.
En una realization particular, la secuencia para el direccionamiento de protemas al cloroplasto es la secuencia de la subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa, y mas particularmente tiene la secuencia mostrada en SEQ ID NO: 8.In a particular embodiment, the sequence for chloroplast protein targeting is the small subunit sequence of the Ribulose 1.5 bisphosphate Carboxylase-Oxygenase, and more particularly it has the sequence shown in SEQ ID NO: 8.
En otra realizacion particular, al menos uno de los transgenes presenta adicionalmente en el extremo 3' una secuencia terminadora de la transcripcion. La secuencia terminadora de la transcripcion puede ser derivada del mismo gen de donde se obtuvo la secuencia promotora de la transcripcion o de un gen distinto. La secuencia terminadora puede ser derivada de genes contenidos en el T-DNA del plasmido Ti de Agrobacterium, del virus del mosaico de la coliflor o de genes de origen vegetal. Por ejemplo, la secuencia terminadora del gen de la nopalina sintetasa es frecuentemente usado en la Ingenieria Genetica de plantas. Mas particularmente la secuencia terminadora empleada es la secuencia terminadora del gen que codifica nopalina sintasa o la secuencia terminadora del gen que codifica la ADP-glucosa pirofosforilasa. Aun mas particularmente, la secuencia terminadora de nopalina sintasa tiene la secuencia mostrada en SEQ ID NO: 9 y la secuencia terminadora de ADP- glucosa pirofosforilasa tiene la secuencia mostrada en SEQ ID NO: 10.In another particular embodiment, at least one of the transgenes additionally has at the 3 'end a transcription terminator sequence. The transcription terminator sequence can be derived from the same gene from which the transcription promoter sequence was obtained or from a different gene. The terminator sequence can be derived from genes contained in the T-DNA of the Ti plasmid from Agrobacterium, from the cauliflower mosaic virus or from genes of plant origin. For example, the terminating sequence of the nopaline synthetase gene is frequently used in plant genetic engineering. More particularly, the terminator sequence used is the terminator sequence of the gene encoding nopaline synthase or the terminator sequence of the gene encoding ADP-glucose pyrophosphorylase. Even more particularly, the nopaline synthase terminator sequence has the sequence shown in SEQ ID NO: 9 and the ADP-glucose pyrophosphorylase terminator sequence has the sequence shown in SEQ ID NO: 10.
55
1010
15fifteen
20twenty
2525
3030
En una realizacion de la presente invencion cuando la planta de ma^z expresa el transgen correspondiente a la fitoeno sintasa con la secuencia mostrada en SEQ ID NO: 1, dicha secuencia presenta adicionalmente en el extremo 3'la secuencia terminadora de nopalina sintasa con la secuencia mostrada en SEQ ID NO: 9.In an embodiment of the present invention when the corn plant expresses the transgene corresponding to the phytoen synthase with the sequence shown in SEQ ID NO: 1, said sequence additionally presents at the 3'-end the nopaline synthase terminator sequence with the sequence shown in SEQ ID NO: 9.
En otra realizacion particular, cuando la planta de maiz expresa el transgen correspondiente a la caroteno desaturasa tiene la secuencia mostrada en SEQ ID NO: 2, dicha secuencia presente adicionalmente en el extremo 3'la secuencia terminadora de ADP- glucosa pirofosforilasa SEQ ID NO: 10. En otra realizacion, la caroteno desaturasa tiene la secuencia mostrada en SEQ ID NO: 2, entonces la caroteno desaturasa forma parte de una protema de fusion que comprende en posicion N con respecto a la caroteno desaturasa una secuencia para el direccionamiento de protemas al cloroplasto, y adicionalmente en el extremo 3'presenta la secuencia terminadora de ADP- glucosa pirofosforilasa SEQ ID NO: 10.In another particular embodiment, when the corn plant expresses the transgene corresponding to carotene desaturase it has the sequence shown in SEQ ID NO: 2, said sequence additionally present at the 3'-terminus sequence of ADP-glucose pyrophosphorylase SEQ ID NO: 10. In another embodiment, the carotene desaturase has the sequence shown in SEQ ID NO: 2, then the carotene desaturase is part of a fusion protein comprising in position N with respect to the carotene desaturase a sequence for addressing proteins to chloroplast, and additionally at the 3'-end it presents the terminating sequence of ADP-glucose pyrophosphorylase SEQ ID NO: 10.
Los transgenes que pueden emplearse en la presente invencion pueden ponerse bajo el control de elementos reguladores que aseguran la expresion en las celulas de las plantas. En general, tales elementos reguladores comprenden un promotor activo en las celulas de las plantas.The transgenes that can be used in the present invention can be placed under the control of regulatory elements that ensure expression in plant cells. In general, such regulatory elements comprise an active promoter in plant cells.
Por tanto, los promotores que pueden ser usados incluyen promotores de la planta que se desea transformar, promotores de otras plantas o de cualquier origen que sean funcionales en la planta blanco y dirijan una expresion constitutiva, inducible o tejido espedfica. Por ejemplo, se pueden utilizar promotores derivados del plasmido Ti de Agrobactertum tumefaciens como son los promotores de la octopina sintetasa, la nopahna sintetasa o la sgropina Sintetasa. Ademas, se pueden incluir otros promotores como el promotor 35S del virus del mosaico de la coliflor o aquellos derivados de geminivirus. Para una revision de promotores utiles puede verse Peremarti A. et al, Plant Mol Biol 73:363378.Therefore, promoters that can be used include promoters of the plant to be transformed, promoters of other plants or of any origin that are functional in the white plant and direct a constitutive, inducible or specific tissue expression. For example, promoters derived from the Ti plasmid of Agrobactertum tumefaciens can be used, such as the promoters of octopine synthetase, nopahna synthetase or sgropin synthetase. In addition, other promoters such as the 35S promoter of cauliflower mosaic virus or those derived from geminivirus can be included. For a review of useful promoters, see Peremarti A. et al, Plant Mol Biol 73: 363378.
La expresion temporal, inducible o tejido espedfica puede ser lograda mediante el uso de promotores o secuencias reguladoras que tienen la especificidad de expresion deseada.Temporary, inducible or specific tissue expression can be achieved through the use of promoters or regulatory sequences that have the desired expression specificity.
55
1010
15fifteen
20twenty
2525
3030
Con objeto de conseguir la expresion en tejidos espedficos de una planta transgenica es posible utilizar promotores espedficos de tejido (vease Stockhaus, EMBO J. 8 (1989), 2245-2251). Se conocen tambien promotores que son espedficamente activos en semillas de diferentes especies de plantas, tales como maiz.In order to achieve expression in specific tissues of a transgenic plant it is possible to use tissue specific promoters (see Stockhaus, EMBO J. 8 (1989), 2245-2251). Promoters are also known that are specifically active in seeds of different plant species, such as corn.
Los elementos reguladores pueden comprender adicionalmente intensificadores de la transcripcion y/o traduccion funcionales en las celulas de las plantas. Adicionalmente, los elementos reguladores pueden incluir senales de terminacion de la transcripcion, tales como una senal poli-A, que conducen a la adicion de una cola poli-A al transcrito que puede mejorar su estabilidad.Regulatory elements may additionally comprise functional transcription and / or translation enhancers in plant cells. Additionally, the regulatory elements may include transcription termination signals, such as a poly-A signal, which lead to the addition of a poly-A tail to the transcript that can improve its stability.
En una realizacion particular el transgen o transgenes se encuentra bajo el control de un promotor espedfico de endospermo.In a particular embodiment the transgene or transgenes is under the control of a specific endosperm promoter.
Promotores espedficos de endospermo utiles en la presente invencion, son entre otros los promotores de genes que codifican para protemas de almacenamiento en semillas, Galili y col., 1993, Trends Cell Biol 3:437-442. Las prolaminas, son las protemas de almacenamiento de cereales mas abundantes, en maiz las zemas (zemas a, p, y y 5- zemas, en trigo las gluteninas, en cebada hordema, secalina en centeno y acenina en avena.Specific endosperm promoters useful in the present invention are, among others, gene promoters that code for seed storage proteins, Galili et al., 1993, Trends Cell Biol 3: 437-442. Prolamines are the most abundant cereal storage proteins, in corn the zemas (zemas a, p, and 5- zemas, in wheat the glutenins, in barley hordema, secalin in rye and acenin in oats.
Ejemplos ilustrativos, no limitativos, de promotores espedficos de endospermo que pueden emplearse en la presente invencion son entre otros los promotores de glutenina LMW de trigo, hordema de cebada, prolamina de arroz, glutelina 1 de arroz, zema de maiz, de zeina 27 Kda, ADP-glucosa pirofosforilasa de arroz, glutelina I de arroz tal y como se describe en Russel DA. et al., Transgenic research 6, 157-168 (1997). Tambien son utiles, los promotores de MEG-1 tal y como se describe en EP1680506B1.Illustrative, non-limiting examples of specific endosperm promoters that can be used in the present invention are among others the promoters of wheat LMW glutenin, barley hordema, rice prolamine, rice glutelin 1, corn zema, zeina 27 Kda , ADP-glucose rice pyrophosphorylase, rice glutelin I as described in Russel DA. et al., Transgenic research 6, 157-168 (1997). Also useful are the promoters of MEG-1 as described in EP1680506B1.
En una realizacion particular el promotor espedfico de endospermo es el promotor de D- hordema o el promotor de LMW glutenina. Mas particularmente el promotor de D-hordema es de cebada con secuencia mostrada en SEQ ID NO: 12 o del promotor de LMW glutenina de trigo con secuencia mostrada en SEQ ID NO: 11.In a particular embodiment, the specific endosperm promoter is the D-hordema promoter or the LMW glutenin promoter. More particularly, the D-hordema promoter is barley with sequence shown in SEQ ID NO: 12 or LMW wheat glutenin promoter with sequence shown in SEQ ID NO: 11.
55
1010
15fifteen
20twenty
2525
3030
En una forma preferida de realization, el gen de la fitoeno sintasa se encuentra bajo control del promotor de la LMW glutenina, preferiblemente del promotor de la LMW glutenina de trigo. En otra forma preferida de realizacion, el gen de la carotena desaturasa se encuentra bajo control del promotor de la D-hordeina, preferiblemente del promotor de la D-hordeina de cebada.In a preferred form of realization, the phytoeno synthase gene is under the control of the LMW glutenin promoter, preferably of the LMW wheat glutenin promoter. In another preferred embodiment, the carotene desaturase gene is under the control of the D-hordein promoter, preferably of the barley D-hordein promoter.
La diferentes secuencias de acidos nucleicos que forman parte de la molecula de ADN recombinante pueden ser unidas por metodos convencionales descritos en la literatura. Las secuencias deben ser clonadas y unidas en la orientation y orden correcto para lograr la expresion funcional en celulas vegetales.The different nucleic acid sequences that are part of the recombinant DNA molecule can be linked by conventional methods described in the literature. The sequences must be cloned and linked in the correct orientation and order to achieve functional expression in plant cells.
De acuerdo con uno de los aspectos de esta invention, las plantas de interes son transformadas con una o varias moleculas de ADN recombinante. En el desarrollo de la molecula recombinante, las diferentes secuencias nucleotidicas que la componen y que comprenden las secuencias regulatorias de la transcription y la secuencia codificante de interes, pueden haber sido sujetas a diferentes tipos de procesamiento, como son ligaciones, digestiones con enzimas de restriction, mutagenesis in vitro, adicion de oligonucleotidos o modificaciones por medio de la reaction de polimerizacion en cadena (PCR). Por lo tanto, los componentes de la molecula recombinante antes de ser unidos pueden estar sujetos a deleciones, inserciones o modificaciones internas. Como la molecula recombinante es derivada de componentes que se originan de diferentes organismos y que han sido aislados, purificados o sintetizados, no es una molecula que existe como tal en la naturaleza.According to one of the aspects of this invention, the plants of interest are transformed with one or more recombinant DNA molecules. In the development of the recombinant molecule, the different nucleotide sequences that compose it and that comprise the regulatory sequences of the transcription and the coding sequence of interest, may have been subject to different types of processing, such as ligaments, digestion with restriction enzymes , in vitro mutagenesis, addition of oligonucleotides or modifications by means of the chain polymerization reaction (PCR). Therefore, the components of the recombinant molecule before being bound may be subject to deletions, insertions or internal modifications. Since the recombinant molecule is derived from components that originate from different organisms and that have been isolated, purified or synthesized, it is not a molecule that exists as such in nature.
Dependiendo del metodo de transformation utilizado para introducir la molecula recombinante a la celula vegetal de interes, puede ser necesario la inclusion de otras secuencias de ADN. Por ejemplo, es necesario incluir un vector de donation molecular que permita su replication en E. coli y, para algunos casos, que permita la replication en A. tumefaciens. Para el uso del sistema de transformacion genetica mediada por el plasmido Ti de Agrobacterium para introducir la molecula recombinante en el genoma de la celula vegetal, es necesario incluir las secuencias bordes del T-DNA, de manera tal que esten presentes a ambos extremos del gen que codifica la enzima que sintetiza acidos organicos y en algunos casos el gen de selection dominante. El uso de cepas deDepending on the transformation method used to introduce the recombinant molecule to the plant cell of interest, the inclusion of other DNA sequences may be necessary. For example, it is necessary to include a molecular donation vector that allows its replication in E. coli and, for some cases, that allows replication in A. tumefaciens. For the use of the Agrobacterium Ti plasmid-mediated genetic transformation system to introduce the recombinant molecule into the genome of the plant cell, it is necessary to include the T-DNA border sequences, so that they are present at both ends of the gene which encodes the enzyme that synthesizes organic acids and in some cases the dominant selection gene. The use of strains of
55
1010
15fifteen
20twenty
2525
3030
Agrobacterium desarmadas, es decir aquellas a las que se les han removido los genes responsables de la formation de tumores, pero que mantienen la capacidad de transferir ADN a celulas vegetales, permite la regeneration de plantas transgenicas que contienen la molecula recombinante de interes.Disarmed agrobacterium, that is, those whose genes responsible for tumor formation have been removed, but which maintain the ability to transfer DNA to plant cells, allows the regeneration of transgenic plants that contain the recombinant molecule of interest.
Tambien generalmente se incluye un gen de selection dominante que permita identificar y seleccionar las celulas que incorporaron de manera estable la molecula recombinante en su genoma. A modo de ejemplo ilustrativo no limitativo, los genes marcadores pueden ser la mutation rrn16 (16S rRNA) que confiere resistencia a espectinomicina y estreptinomicina, la mutacion rps12 (ribosoma) que confiere resistencia aA dominant selection gene is also generally included to identify and select the cells that stably incorporated the recombinant molecule into their genome. As an illustrative, non-limiting example, the marker genes can be the mutation rrn16 (16S rRNA) that confers resistance to spectinomycin and streptinomycin, the mutation rps12 (ribosome) that confers resistance to
estreptinomicina, gen aadA (E. coli) que codifica la enzima aminoglucosido 3’ adeniltransferasa que confiere resistencia a los antibioticos espectinomicina y estreptinomicina, gen nptll procedente del transposon bacteriano Tn5 codifica la enzima neomicina fosfotransferasa que confiere resistencia al antibiotico kanamicina, el gen aphA-6 de Acinetobacter baumannii que codifica la enzima aminoglucosido fosfotransferasa la cual le confiere resistencia al antibiotico kanamicina, gen cat de E. coli confiere resistencia a cloranfenicol, gen ASA2 responsable de la resistencia a analogos del triptofano, el gen bar de Streptomyces hygroscopicus que codifica para la enzima fosfinotricina acetil transferasa (PAT) que confiere resistencia a fosfinotricina y el gen pat de Streptomyces viridochromogenes convierten el glufosinato de amonio en nacetil glufosinato que es un compuesto no fitotoxico para la planta.Streptinomycin, aadA gene (E. coli) that encodes the 3 'adenyltransferase aminoglycoside enzyme that confers resistance to the antibiotic spectinomycin and streptinomycin, nptll gene from the bacterial transposon Tn5 encodes the enzyme neomycin phosphotransferase that confers resistance to the antibiotic kanamycin, the antibiotic kanamycin, the antibiotic 6 of Acinetobacter baumannii that encodes the enzyme aminoglycoside phosphotransferase which confers resistance to the antibiotic kanamycin, E. coli cat gene confers resistance to chloramphenicol, ASA2 gene responsible for the analog resistance of tryptophan, the Streptomyces hygroscopicus bar gene that codes for The enzyme phosphinothricin acetyl transferase (PAT) that confers resistance to phosphinothricin and the Streptomyces viridochromogenes pat gene convert ammonium glufosinate into nacetyl glufosinate which is a non-phytotoxic compound for the plant.
En una realization preferida el gen de seleccion es el gen bar. En una realization mas particular, el gen bar tiene la secuencia mostrada en SEQ ID NO: 5.In a preferred embodiment the selection gene is the bar gene. In a more particular embodiment, the bar gene has the sequence shown in SEQ ID NO: 5.
Dependiendo del tipo de gen de seleccion que se incluya, puede ser aconsejable que una vez se ha identificado la planta transgenica, se elimine el gen marcador de seleccion de la planta.Depending on the type of selection gene that is included, it may be advisable that once the transgenic plant has been identified, the plant selection marker gene is eliminated.
En otra realizacion particular de la composition nutritiva o nutraceutico de la invention, la parte de la planta de maiz o un derivado de la misma esta enriquecida en un carotenoide seleccionado del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive or nutraceutical composition of the invention, the part of the corn plant or a derivative thereof is enriched in a carotenoid selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin , beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
55
1010
15fifteen
20twenty
2525
3030
equinenona, zeaxantina, Z-fitoeno, fitoeno y combinaciones de los mismos (composicion nutritiva B o nutraceutico B).equinenone, zeaxanthin, Z-phytoen, phytoen and combinations thereof (nutritional composition B or nutraceutical B).
En una realizacion particular de la composicion nutritiva B o nutraceutico B de la invention, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona, zeaxantina, Z-fitoeno, fitoeno.In a particular embodiment of the nutritional composition B or nutraceutical B of the invention, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone, zeaxanthin, Z-phytoen, phytoen.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 2 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona, zeaxantina, Z-fitoeno y fitoeno, incluyendo cualquier combination de los mismos.In another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 2 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone, zeaxanthin, Z-phytoene and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 3 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 3 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno, incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 4 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 4 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, canthaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno, fitoeno y combinaciones de los mismos.equinenone, zeaxanthin, Z-phytoen, phytoen and combinations thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 5 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 5 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
55
1010
15fifteen
20twenty
2525
3030
equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realization particular de la composition nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 6 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 6 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 7 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 7 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 8 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 8 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 9 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 9 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 10 carotenoidesIn another particular embodiment of the nutritional composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 10 carotenoids
55
1010
15fifteen
20twenty
2525
3030
seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 11 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 11 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno , incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 12 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OHIn another particular embodiment of the nutritive composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 12 carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH
equinenona, zeaxantina, Z-fitoeno y fitoeno, incluyendo cualquier combinacion de los mismos.equinenone, zeaxanthin, Z-phytoen and phytoen, including any combination thereof.
En otra realizacion particular de la composicion nutritiva B o nutraceutico B, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 13 carotenoides, concretamente astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno,In another particular embodiment of the nutritional composition B or nutraceutical B, the part of the corn plant or derivative thereof is enriched in 13 carotenoids, specifically astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene,
cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona,cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone,
zeaxantina, Z-fitoeno y fitoeno.zeaxanthin, Z-phytoen and phytoen.
En otra realizacion de la composicion B nutritiva o nutraceutico B de la invencion la parte de la planta de maiz o derivado de la misma enriquecida en antioxidantes expresa un transgen que codifica una fitoeno sintasa, un transgen que codifica una beta caroteno cetolasa y un transgen que codifica una beta caroteno hidroxilasa. En otra realizacion de dicha composicion, la planta de maiz enriquecida en antioxidantes, expresa adicionalmente un ARNi espedfico de la licopeno epsilon ciclasa de maiz.In another embodiment of the nutritive or nutraceutical composition B of the invention, the part of the corn plant or derivative thereof enriched in antioxidants expresses a transgene encoding a phytoen synthase, a transgene encoding a beta carotene ketolase and a transgene encodes a beta carotene hydroxylase. In another embodiment of said composition, the antioxidant-enriched corn plant additionally expresses a specific RNAi of the corn lycopene epsilon cyclase.
55
1010
15fifteen
20twenty
2525
3030
En otra realizacion de la composicion nutritiva o nutraceutico de la invention la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en un carotenoide seleccionado del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona y combinaciones de los mismos (composicion nutritiva C o nutraceutico C).In another embodiment of the nutritive or nutraceutical composition of the invention the part of the corn plant or derivative thereof is enriched in a carotenoid selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin, 3-OH equinenone and combinations thereof (nutritional composition C or nutraceutical C).
En una realizacion particular de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona.In a particular embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene , cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin and 3-OH equinenone.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 2 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 2 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone,
incluyendo cualquier combination de los mismos.including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 3 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 3 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone,
incluyendo cualquier combinacion de los mismos.including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 4 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 4 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone,
incluyendo cualquier combinacion de los mismos.including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 5 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 5 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene,
55
1010
15fifteen
20twenty
2525
3030
cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona, incluyendo cualquier combinacion de los mismos.Cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin and 3-OH equinenone, including any combination thereof.
En otra realization de la composition nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 6 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 6 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone,
incluyendo cualquier combinacion de los mismos.including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 7 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 7 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone,
incluyendo cualquier combinacion de los mismos.including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 8 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona,In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 8 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone,
incluyendo cualquier combinacion de los mismos.including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma nutraceutico se encuentra enriquecida en 9 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona, incluyendo cualquier combinacion de los mismos.In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative of the same nutraceutical is enriched in 9 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin and 3-OH equinenone, including any combination thereof.
En otra realizacion de la composicion nutritiva C o nutraceutico C, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en 10 carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona, incluyendo cualquier combinacion de los mismos.In another embodiment of the nutritive composition C or nutraceutical C, the part of the corn plant or derivative thereof is enriched in 10 carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta -criptoxanthin, adonixanthin, adonirubin and 3-OH equinenone, including any combination thereof.
55
1010
15fifteen
20twenty
2525
3030
En otra realizacion de la composicion nutritiva C o nutraceutico C de la invencion, la parte de la planta de maiz o derivado de la misma enriquecida en antioxidantes procede del cruzamiento entre una lmea de maiz con alto nivel de aceite y un maiz que expresa un transgen que codifica una fitoeno sintasa, un transgen que codifica una beta caroteno cetolasa y un transgen que codifica una beta caroteno hidroxilasa. En una realizacion mas particular, el maiz que expresa un transgen que codifica una fitoeno sintasa, un transgen que codifica una beta caroteno cetolasa y un transgen que codifica una beta caroteno hidroxilasa expresa adicionalmente un ARNi espedfico de la licopeno epsilon ciclasa de maiz.In another embodiment of the nutritive composition C or nutraceutical C of the invention, the part of the corn plant or derivative thereof enriched in antioxidants comes from the cross between a corn line with high oil level and a corn expressing a transgene which encodes a phytoeno synthase, a transgene that encodes a beta carotene ketolase and a transgene that encodes a beta carotene hydroxylase. In a more particular embodiment, corn expressing a transgene encoding a phytoen synthase, a transgene encoding a beta carotene ketolase and a transgene encoding a beta carotene hydroxylase further expresses a specific RNA of lycopene epsilon cyclase corn.
El experto en la materia conoce diversos metodos para identificar una planta de maiz con alto nivel de aceite, a modo de ejemplo ilustrativo no limitativo mediante la determination del contenido de aceite en grano de maiz empleando la metodologia descrita en Galicia, L., E. Nurit, A. Rosales, and N. Palacios-Rojas. 2009. Maize Nutrition Quality and Plant Tissue Analysis Laboratory. Laboratory Protocols 2008. Centro Internacional de Mejoramiento de Maiz y Trigo. Mexico, D.F. 42 p. Se puede considerar que una planta de maiz presenta alto nivel de aceite, cuando el nivel de aceite en los granos de maiz es al menos un 6% mayor que el contenido en granos de un maiz silvestre.The person skilled in the art knows various methods to identify a corn plant with a high level of oil, by way of illustrative non-limiting example by determining the content of corn grain oil using the methodology described in Galicia, L., E. Nurit, A. Rosales, and N. Palacios-Rojas. 2009. Maize Nutrition Quality and Plant Tissue Analysis Laboratory. Laboratory Protocols 2008. International Corn and Wheat Improvement Center. Mexico DF. 42 p. A corn plant can be considered to have a high level of oil, when the level of oil in the corn kernels is at least 6% higher than the grain content of a wild corn.
En otra realizacion particular de la composicion nutritiva C o nutraceutico C de la invencion, la lmea de maiz con alto nivel de aceite es la lmea NSL30876.In another particular embodiment of the nutritive composition C or nutraceutical C of the invention, the corn line with high oil level is the NSL30876 line.
En una realizacion particular de las composiciones nutritivas B y Co nutraceuticos B y C de la invencion, las secuencias de los trangenes tienen adaptados los codones para su expresion en plantas.In a particular embodiment of the nutritive compositions B and Co nutraceuticals B and C of the invention, the sequences of the trangenes have adapted the codons for their expression in plants.
En otra realizacion particular de las composiciones B y C de la invencion el transgen que codifica una fitoeno sintasa procede de Zea mays y tiene la secuencia mostrada en SEQ ID NO: 1, el transgen que codifica una beta caroteno cetolasa procede de Chlamydomonas reinhardtii y tiene la secuencia mostrada en SEQ ID NO: 14, el transgen que codifica una beta caroteno hidroxilasa procede de Brevidomonas sp. y tiene laIn another particular embodiment of the compositions B and C of the invention the transgene encoding a phytoeno synthase comes from Zea mays and has the sequence shown in SEQ ID NO: 1, the transgene encoding a beta carotene ketolase comes from Chlamydomonas reinhardtii and has The sequence shown in SEQ ID NO: 14, the transgene encoding a beta carotene hydroxylase comes from Brevidomonas sp. and has the
55
1010
15fifteen
20twenty
2525
3030
secuencia mostrada en SEQ ID NO: 15 y/o el ARNi espedfico de la licopeno epsilon ciclasa de maiz tiene la secuencia mostrada en SEQ ID NO: 16.sequence shown in SEQ ID NO: 15 and / or the specific RNAi of corn lycopene epsilon cyclase has the sequence shown in SEQ ID NO: 16.
En otra realization particular de las composiciones B y C de la invention si el transgen que codifica una beta caroteno cetolasa tiene la secuencia mostrada en SEQ ID NO: 14 y/o el transgen que codifica una beta caroteno hidroxilasa tiene la secuencia mostrada en SEQ ID NO: 15, entonces la protema codificada por dichos genes se encuentra formando parte de una protema de fusion que comprende una secuencia para el direccionamiento de protemas al cloroplasto. Particularmente, la secuencia para el direccionamiento de protemas al cloroplasto es la secuencia que codifica la subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa y mas particularmente la secuencia que codifica la subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa tiene la secuencia mostrada en SEQ ID NO:8.In another particular embodiment of the compositions B and C of the invention if the transgene encoding a beta carotene ketolase has the sequence shown in SEQ ID NO: 14 and / or the transgene encoding a beta carotene hydroxylase has the sequence shown in SEQ ID NO: 15, then the protein encoded by said genes is part of a fusion protein that comprises a sequence for the direction of chloroplast proteins. Particularly, the sequence for chloroplast protein targeting is the sequence that encodes the small subunit of the Ribulose 1.5 bisphosphate Carboxylase-Oxygenase and more particularly the sequence that encodes the small subunit of the Ribulose 1.5 bisphosphate Carboxylase-Oxygenase has the sequence shown in SEQ ID NO: 8.
En otra realizacion particular de las composiciones B y C de la invencion, al menos un transgen o ARNi se encuentran bajo el control de un promotor espedfico de endospermo, particularmente el promotor espedfico de endospermo se selecciona de entre el promotor de D-hordema, el promotor de LMW glutenina y el promotor de gamma-zeina. Mas particulamente, el promotor de D-hordema tiene la secuencia mostrada en SEQ ID NO: 12, el promotor de LMW glutenina tiene la secuencia mostrada en SEQ ID NO: 11 y el promotor de gamma-zeina tiene la secuencia mostrada en SEQ ID NO: 13.In another particular embodiment of the compositions B and C of the invention, at least one transgene or RNAi is under the control of a specific endosperm promoter, particularly the specific endosperm promoter is selected from the D-hordema promoter, the LMW glutenin promoter and gamma-zein promoter. More particularly, the D-hordema promoter has the sequence shown in SEQ ID NO: 12, the LMW glutenin promoter has the sequence shown in SEQ ID NO: 11 and the gamma-zein promoter has the sequence shown in SEQ ID NO : 13.
En otra realizacion, el transgen comprende adicionalmente en el extremo 3' la region 5'UTR del gen de la alcohol deshidrogenasa de arroz, mas particularmente dicha region tiene la secuencia mostrada en SEQ ID NO: 17.In another embodiment, the transgene further comprises at the 3 'end the 5'UTR region of the rice alcohol dehydrogenase gene, more particularly said region has the sequence shown in SEQ ID NO: 17.
Usos de las composiciones de la invencion.Uses of the compositions of the invention.
En otro aspecto, la invencion se relaciona con el uso de una composition nutritiva o nutraceutico segun cualquiera la invencion (composicion nutritiva A, Bo C, o nutraceutico A, B o C) para la obtencion de huevos enriquecidos en antioxidantes.In another aspect, the invention relates to the use of a nutritive or nutraceutical composition according to any one of the invention (nutritive composition A, Bo C, or nutraceutical composition A, B or C) for obtaining eggs enriched in antioxidants.
55
1010
15fifteen
20twenty
2525
3030
Un experto en la materia conoce diversos metodos para determinar el nivel de antioxidantes tal y como se ha explicado en detalles anteriormente, en relation con una planta enriquecida en antioxidantes.One skilled in the art knows various methods for determining the level of antioxidants as explained in detail above, in relation to a plant enriched in antioxidants.
Las composiciones de la invention pueden emplearse para la obtencion de huevos enriquecidos en antioxidantes de cualquier individuo oviparo hembra que sea alimentada con dichas composiciones.The compositions of the invention can be used to obtain antioxidant-enriched eggs from any female oviparo individual that is fed with said compositions.
En una realization preferida los huevos son huevos de un ave de corral, mas particularmente de gallina.In a preferred embodiment the eggs are eggs of a poultry, more particularly of chicken.
Usos de una parte de una planta de malz enriquecida en antioxidantes o un derivado de la mismaUses of a part of an antioxidant-enriched maize plant or a derivative thereof
En otro aspecto, la invencion se relaciona con el uso de una parte de una planta de maiz enriquecida en antioxidantes o un derivado de la misma para la obtencion de huevos enriquecidos en antioxidantes.In another aspect, the invention relates to the use of a part of a corn plant enriched in antioxidants or a derivative thereof for obtaining eggs enriched in antioxidants.
En una realizacion particular del uso de la invencion, la parte de la planta de maiz es el endospermo, la semilla o derivados de los mismos.In a particular embodiment of the use of the invention, the part of the corn plant is the endosperm, the seed or derivatives thereof.
En otra realizacion particular, los antioxidantes que se encuentran enriquecidos en una parte de una planta de maiz o en un derivado de la misma son carotenoides.In another particular embodiment, the antioxidants that are enriched in a part of a corn plant or in a derivative thereof are carotenoids.
En una realizacion mas particular del uso de la invencion, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en carotenoides seleccionados del grupo formado por p-caroteno, Y-caroteno, a-caroteno, a-criptoxantina, p-criptoxantina, licopeno, lutema, zeaxantina y combinaciones de los mismos (uso A de la invencion)In a more particular embodiment of the use of the invention, the part of the corn plant or derivative thereof is enriched in carotenoids selected from the group consisting of p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p -criptoxanthin, lycopene, lutema, zeaxanthin and combinations thereof (use A of the invention)
En una realizacion particular del uso A de la invencion, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides, o en 2, 3, 4, 5, 6, 7 u 8 seleccionados de p-caroteno, Y-caroteno, a-caroteno, a-criptoxantina, p- criptoxantina, licopeno, lutema, zeaxantina y combinaciones de los mismos.In a particular embodiment of the use A of the invention, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids, or in 2, 3, 4, 5, 6, 7 or 8 selected from p-carotene, Y-carotene, a-carotene, a-cryptoxanthin, p-cryptoxanthin, lycopene, lutema, zeaxanthin and combinations thereof.
55
1010
15fifteen
20twenty
2525
3030
Todas las combinaciones mencionadas anteriormente, en relation con la composition nutritiva A o nutraceutico A de la invention, son igualmente aplicables a este aspecto.All the aforementioned combinations, in relation to the nutritive composition A or nutraceutical A of the invention, are equally applicable to this aspect.
En otra realization del uso A de la invencion la parte de la planta de maiz o derivado de la misma enriquecida en antioxidantes es una planta de maiz transgenica que expresa al menos un transgen que codifica una fitoeno sintasa y un transgen que codifica una caroteno desaturasa. En otra realizacion, la planta de maiz expresa adicionalmente un transgen seleccionado del grupo formado por un transgen que codifica una licopeno p- ciclasa, un transgen que codifica una p-caroteno hidroxilasa y un transgen que codifica una carotenoide cetolasa.In another embodiment of the use A of the invention, the part of the corn plant or derivative thereof enriched in antioxidants is a transgenic corn plant that expresses at least one transgene encoding a phytoen synthase and a transgene encoding a carotene desaturase. In another embodiment, the corn plant further expresses a transgene selected from the group consisting of a transgene encoding a lycopene p-cyclase, a transgene encoding a p-carotene hydroxylase and a transgene encoding a carotenoid ketolase.
En una realizacion particular, las secuencias de los transgenes tienen adaptados los codones para su expresion en plantas.In a particular embodiment, the sequences of the transgenes have the codons adapted for expression in plants.
En una realizacion particular, el transgen que codifica la fitoeno sintasa tiene la secuencia mostrada en SEQ ID NO: 1, el transgen que codifica la caroteno desaturasa tiene la secuencia mostrada en SEQ ID NO: 2, el transgen que codifica la licopeno p-ciclasa tiene la secuencia mostrada en SEQ ID NO:3, el transgen que codifica la p-caroteno hidroxilasa tiene la secuencia mostrada en SEQ ID NO:4 o SEQ ID NO:6 y/o el transgen que codifica la carotenoide cetolasa tiene la secuencia mostrada en SEQ ID NO:7.In a particular embodiment, the transgene encoding the phytoen synthase has the sequence shown in SEQ ID NO: 1, the transgene encoding the carotene desaturase has the sequence shown in SEQ ID NO: 2, the transgene encoding the lycopene p-cyclase has the sequence shown in SEQ ID NO: 3, the transgene encoding p-carotene hydroxylase has the sequence shown in SEQ ID NO: 4 or SEQ ID NO: 6 and / or the transgene encoding carotenoid ketolase has the sequence shown in SEQ ID NO: 7.
En otra realizacion mas particular, si el transgen que codifica una caroteno desaturasa tiene la secuencia mostrada en SEQ ID NO: 2 entonces la protema codificada por dicho gen se encuentra formando parte de una protema de fusion que comprende en el extremo 5' una secuencia para el direccionamiento de protemas al cloroplasto, mas particularmente la secuencia que codifica la subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa, y mas particularmente dicha secuencia, tiene la secuencia mostrada en SEQ ID NO: 8.In another more particular embodiment, if the transgene encoding a carotene desaturase has the sequence shown in SEQ ID NO: 2 then the protein encoded by said gene is forming part of a fusion protein comprising at the 5 'end a sequence for Chloroplast protein targeting, more particularly the sequence encoding the small subunit of Ribulose 1.5 bisphosphate Carboxylase-Oxygenase, and more particularly said sequence, has the sequence shown in SEQ ID NO: 8.
En otra realizacion, si el transgen que codifica una fitoeno sintasa tiene la secuencia mostrada en SEQ ID NO: 1, dicha secuencia presenta adicionalmente en el extremo 3' la secuencia terminadora de nopalina sintasa con la secuencia mostrada en SEQ ID NO: 9.In another embodiment, if the transgene encoding a phytoen synthase has the sequence shown in SEQ ID NO: 1, said sequence additionally presents at the 3 'end the nopaline synthase terminator sequence with the sequence shown in SEQ ID NO: 9.
55
1010
15fifteen
20twenty
2525
3030
Los trangenes pueden presentar adicionalmente en el extremo 3' una secuencia terminadora de la transcription, particularmente es la secuencia terminadora de nopalina sintasa o la secuencia terminadora de ADP-glucosa pirofosforilasa. Mas particularmente la secuencia terminadora de nopalina sintasa tiene la secuencia mostrada en SEQ ID NO: 9 y la secuencia terminadora de ADP- glucosa pirofosforilasa tiene la secuencia mostrada en SEQ ID NO: 10.The trangenes may additionally present at the 3 'end a transcription terminator sequence, particularly the nopaline synthase terminator sequence or the ADP-glucose pyrophosphorylase terminator sequence. More particularly the nopaline synthase terminator sequence has the sequence shown in SEQ ID NO: 9 and the ADP-glucose pyrophosphorylase terminator sequence has the sequence shown in SEQ ID NO: 10.
De acuerdo a este aspecto, un al menos un transgen se encuentra bajo el control de un promotor espedfico de endospermo, particularmente el promotor espedfico de endospermo es el promotor de D-hordema o el promotor de LMW glutenina. Mas particularmente, el promotor de D-hordema tiene la secuencia mostrada en SEQ ID NO: 12 y el promotor de LMW glutenina tiene la secuencia mostrada en SEQ ID NO: 11.According to this aspect, at least one transgene is under the control of a specific endosperm promoter, particularly the specific endosperm promoter is the D-hordema promoter or the LMW glutenin promoter. More particularly, the D-hordema promoter has the sequence shown in SEQ ID NO: 12 and the LMW glutenin promoter has the sequence shown in SEQ ID NO: 11.
En otra realization, la parte de la planta de maiz o derivado de la misma esta enriquecida en carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona, zeaxantina, Z-fitoeno, fitoeno y combinaciones de los mismos (uso B de la invention).In another embodiment, the part of the corn plant or derivative thereof is enriched in carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone, zeaxanthin, Z-phytoen, phytoen and combinations thereof (use B of the invention).
En una realizacion particular del uso B de la invencion, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides seleccionados del grupo formado por astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona, zeaxantina, Z-fitoeno y fitoeno.In a particular embodiment of the use B of the invention, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids selected from the group consisting of astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin , beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone, zeaxanthin, Z-phytoen and phytoen.
En una realizacion particular, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides, o en 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 o 13 seleccionados de astaxantina, violaxantina, anteraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona,In a particular embodiment, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids, or in 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13 selected from astaxanthin, violaxanthin, anteraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone,
zeaxantina, Z-fitoeno y fitoeno, incluyendo todas las posibles combinaciones.zeaxanthin, Z-phytoen and phytoen, including all possible combinations.
55
1010
15fifteen
20twenty
2525
3030
En una realization particular del uso B de la invention, la parte de la planta de ma^z o derivado de la misma enriquecida en antioxidantes expresa un transgen que codifica una fitoeno sintasa, un transgen que codifica una beta caroteno cetolasa y un transgen que codifica una beta caroteno hidroxilasa, y mas particularmente expresa adicionalmente un ARNi espetifico de la licopeno epsilon ciclasa de maiz.In a particular embodiment of the use B of the invention, the part of the plant derived from it enriched in antioxidants expresses a transgene encoding a phytoeno synthase, a transgene encoding a beta carotene ketolase and a transgene encoding a beta carotene hydroxylase, and more particularly expresses additionally a specific RNAi of corn lycopene epsilon cyclase.
Todas las combinaciones mencionadas anteriormente, en relation con la composition nutritiva B o nutraceutico B de la invencion, son igualmente aplicables al uso B de la invencion.All the combinations mentioned above, in relation to the nutritional composition B or nutraceutical B of the invention, are equally applicable to the use B of the invention.
En otra realizacion particular, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona y combinaciones de los mismos (uso C de la invencion).In another particular embodiment, the part of the corn plant or derivative thereof is enriched in carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3 -OH equinenone and combinations thereof (use C of the invention).
En una realizacion particular del uso C de la invencion, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides seleccionados del grupo formado por astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina y 3-OH equinenona.In a particular embodiment of the use C of the invention, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids selected from the group consisting of astaxanthin, violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin , beta-cryptoxanthin, adonixanthin, adonirubin and 3-OH equinenone.
En una realizacion particular, la parte de la planta de maiz o derivado de la misma se encuentra enriquecida en uno solo de los carotenoides, o en 2, 3, 4, 5, 6, 7, 8, 9 o 10, seleccionados de astaxantina, violaxantina, antheraxantina, lutema, beta-caroteno, cantaxantina, beta-criptoxantina, adonixantina, adonirubina, 3-OH equinenona incluyendo todas las posibles combinaciones.In a particular embodiment, the part of the corn plant or derivative thereof is enriched in only one of the carotenoids, or in 2, 3, 4, 5, 6, 7, 8, 9 or 10, selected from astaxanthin , violaxanthin, antheraxanthin, lutema, beta-carotene, cantaxanthin, beta-cryptoxanthin, adonixanthin, adonirubin, 3-OH equinenone including all possible combinations.
Todas las combinaciones mencionadas anteriormente, en relacion con la composicion nutritiva C o nutraceutico C de la invencion, son igualmente aplicables a este aspecto.All the combinations mentioned above, in relation to the nutritive composition C or nutraceutical C of the invention, are equally applicable to this aspect.
En una realizacion particular del uso C de la invencion, la planta de maiz enriquecida en antioxidantes procede del cruzamiento entre una lmea de maiz con alto nivel de aceite,In a particular embodiment of the use C of the invention, the antioxidant-enriched corn plant comes from the cross between a corn line with a high level of oil,
55
1010
15fifteen
20twenty
2525
3030
particularmente la lmea NSL30876 y un maiz que expresa un transgen que codifica una fitoeno sintasa, un transgen que codifica una beta caroteno cetolasa, un transgen que codifica una beta caroteno hidroxilasa. Mas particularmente, la planta expresa adicionalmente un ARNi espedfico de la licopeno epsilon ciclasa de maiz.particularly the NSL30876 line and a corn expressing a transgene encoding a phytoen synthase, a transgene encoding a beta carotene ketolase, a transgene encoding a beta carotene hydroxylase. More particularly, the plant additionally expresses a specific RNAi of corn lycopene epsilon cyclase.
En otra realizacion particular, las secuencias de los trangenes tienen adaptados los codones para su expresion en plantas. Mas particularmente, el transgen que codifica una fitoeno sintasa tiene la secuencia mostrada en SEQ ID NO: 1, el transgen que codifica una beta caroteno cetolasa tiene la secuencia mostrada en SEQ ID NO: 14, el transgen que codifica una beta caroteno hidroxilasa tiene la secuencia mostrada en SEQ ID NO: 15 y/o el ARNi espedfico de la licopeno epsilon ciclasa de maiz con secuencia SEQ ID NO: 16.In another particular embodiment, the trangenes sequences have the codons adapted for expression in plants. More particularly, the transgene encoding a phytoen synthase has the sequence shown in SEQ ID NO: 1, the transgene encoding a beta carotene ketolase has the sequence shown in SEQ ID NO: 14, the transgene encoding a beta carotene hydroxylase has the sequence shown in SEQ ID NO: 15 and / or the specific RNAi of corn lycopene epsilon cyclase with sequence SEQ ID NO: 16.
Al menos un transgen o ARNi se pueden encontrar bajo el control de un promotor espedfico de endospermo, particularmente el promotor espedfico de endospermo se selecciona de entre el promotor de D-hordema, el promotor de LMW glutenina y el promotor de gamma-zeina y mas particularmente el promotor de D-hordema tiene la secuencia mostrada en SEQ ID NO:12 , el promotor de LMW glutenina tiene la secuencia mostrada en SEQ ID NO: 11 y el promotor de gamma-zeina tiene la secuencia mostrada en SEQ ID NO: 13.At least one transgene or RNAi can be found under the control of a specific endosperm promoter, particularly the specific endosperm promoter is selected from the D-hordema promoter, the LMW glutenin promoter and the gamma-zein promoter and more particularly the D-hordema promoter has the sequence shown in SEQ ID NO: 12, the LMW glutenin promoter has the sequence shown in SEQ ID NO: 11 and the gamma-zein promoter has the sequence shown in SEQ ID NO: 13 .
En otra realizacion particular de los usos B y C de la invencion, si el transgen que codifica para una beta caroteno cetolasa tiene la secuencia SEQ ID NO: 14 y/o el transgen que codifica para la beta caroteno hidroxilasa tiene la secuencia SEQ ID NO: 15, entonces el transgen presenta en el extremo 5' una secuencia para el direccionamiento de protemas al cloroplasto. Mas particularmente, la secuencia para el direccionamiento de protemas al cloroplasto es la secuencia que codifica la subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa, mas particularmente, la secuencia que codifica la subunidad pequena de la Ribulosa 1,5 bifosfato Carboxilasa-Oxigenasa tiene la secuencia mostrada en SEQ ID NO: 8.In another particular embodiment of the uses B and C of the invention, if the transgene encoding a beta carotene ketolase has the sequence SEQ ID NO: 14 and / or the transgene encoding the beta carotene hydroxylase has the sequence SEQ ID NO : 15, then the transgene presents at the 5 'end a sequence for the addressing of proteins to the chloroplast. More particularly, the sequence for chloroplast protein targeting is the sequence encoding the small subunit of Ribulose 1.5 bisphosphate Carboxylase-Oxygenase, more particularly, the sequence encoding the small subunit of Ribulose 1.5 bisphosphate Carboxylase- Oxygenase has the sequence shown in SEQ ID NO: 8.
En otra realizacion particular, el transgen comprende adicionalmente en el extremo 3' la region 5'UTR del gen de la alcohol deshidrogenasa de arroz, mas particularmente laIn another particular embodiment, the transgene further comprises at the 3 'end the 5'UTR region of the rice alcohol dehydrogenase gene, more particularly the
55
1010
15fifteen
20twenty
2525
3030
region 5'UTR del gen de la alcohol deshidrogenasa de arroz tiene la secuencia mostrada en SEQ ID NO: 17.5'UTR region of the rice alcohol dehydrogenase gene has the sequence shown in SEQ ID NO: 17.
En otra realization particular, los huevos son huevos de un ave de corral, particularmente gallina.In another particular embodiment, the eggs are eggs of a poultry, particularly chicken.
Todas las realizaciones y limitaciones previamente descritas son igualmente aplicables a este aspecto.All the previously described embodiments and limitations are equally applicable to this aspect.
Huevo y ovoproductosEgg and egg products
En otro aspecto, la invention se relaciona con un huevo y ovoproductos derivados de dicho huevo obtenidos segun cualquier uso de la invencion, concretamente del uso de la composition nutritiva o nutraceutico A, B o C, o usos de la parte de una planta de maiz enriquecida en antioxidantes A, B o C.In another aspect, the invention relates to an egg and egg products derived from said egg obtained according to any use of the invention, specifically the use of the nutritive or nutraceutical composition A, B or C, or uses of the part of a corn plant enriched in antioxidants A, B or C.
Como entendera el experto en la materia, los huevos de la invencion son obtenidos tras alimentar un ave hembra con una composicion nutritiva o nutraceutico A, B o C o con una planta de maiz enriquecida en antioxidantes A, B o C.As the person skilled in the art will understand, the eggs of the invention are obtained after feeding a female bird with a nutritive or nutraceutical composition A, B or C or with a corn plant enriched with antioxidants A, B or C.
Todas las realizaciones y limitaciones previamente descritas son igualmente aplicables a este aspecto.All the previously described embodiments and limitations are equally applicable to this aspect.
MATERIALES Y METODOSMATERIALS AND METHODS
Transformation del MaizCorn Transformation
Ma^zMa ^ z
El maiz (Zea mays) variedad M37W (endospermo blanco) se obtuvo de CSIR, Pretoria, Sudafrica. La lmea de alto aceite NSL 30876 denominada R38 en la presente description fue proporcionado amablemente por el USDA, ARS, NCRPIS, la Universidad Estatal de Iowa, Estacion Regional de Introduction de Plantas, Ames, Iowa, Estados Unidos, 50011-Corn (Zea mays) variety M37W (white endosperm) was obtained from CSIR, Pretoria, South Africa. The NSL 30876 high oil line called R38 in this description was kindly provided by the USDA, ARS, NCRPIS, Iowa State University, Regional Plant Introduction Station, Ames, Iowa, United States, 50011-
55
1010
15fifteen
20twenty
2525
3030
1170. Ambas variedades, la lmea transgenica seleccionada y los cruces, fueron cultivadas en el invernadero a 28 / 20°C temperatura d^a/temperatura noche con un fotoperiodo de 10-h y 60-90% de humedad durante los primeros 50 d^as, seguidos de mantenimiento en 21/18°C temperatura d^a/temperatura noche con un fotoperiodo de 16-h a partir de entonces.1170. Both varieties, the selected transgenic line and the crosses, were grown in the greenhouse at 28/20 ° C temperature d / a night temperature with a photoperiod of 10-h and 60-90% humidity during the first 50 d ^ as, followed by maintenance at 21/18 ° C temperature d / a / night temperature with a photoperiod of 16-h thereafter.
La lmea M37-pH3 ha sido descrita anteriormente en ES2501367A2 y en Naqvi S. et al, PNAS, 2009 vol,. 106, no. 19 paginas 7762-7767.The M37-pH3 line has been previously described in ES2501367A2 and in Naqvi S. et al, PNAS, 2009 vol ,. 106, no. 19 pages 7762-7767.
La lmea M37-BKT fue cruzada con M37W y NSL30876 y generaciones homocigotos T2 y T3 fueron derivados por autofecundacion. Se congelaron en nitrogeno liquido y se almacenaron a -80 °C antes de su uso, muestras de endospermo de semillas inmaduras recogidas a los 30 dias despues de la polinizacion (DAP).The M37-BKT line was crossed with M37W and NSL30876 and homozygous generations T2 and T3 were derived by self-fertilization. They were frozen in liquid nitrogen and stored at -80 ° C before use, samples of immature seeds endosperm collected 30 days after pollination (DAP).
Construccion de vectores y transformacionVector construction and transformation
1) -Construccion P326-Zmpsy1 que comprende el ADNc de fitoeno sintasa 1 de Zea mays dirigidos por el promotor de la glutenina LMW de trigo.1) -Construction P326-Zmpsy1 comprising the Zea mays phytoeno synthase 1 cDNA directed by the wheat glutenin promoter LMW.
El ADNc PSY1 (fitoeno sintasa 1) de Zea mays (zm) fue clonado a partir de la lmea consangumea B73 por RT-PCR con el cebador directo 5’- AGGATCCATGGCCATCATACTCGTACGAG-3’ (SEQ ID NO: 18) con el sitio BamHI (subrayado) y cebador inverso 5’-AGAATTCTAGGTCTGGCCATTTCTCAATG-3’ (SEQ ID NO:19) con sitio EcoRI (subrayado). El plasmido P326-ZmPSY1 (Zhu et al. 2008 Proc Natl Acad Sci USA 105:18232-18237) esta bajo el control del promotor de la glutenina LMW (Colot et al. 1987 EMBO J 6:3559-3564).The PSY1 cDNA (phytoeno synthase 1) from Zea mays (zm) was cloned from the lmea consangumea B73 by RT-PCR with the direct primer 5'- AGGATCCATGGCCATCATACTCGTACGAG-3 '(SEQ ID NO: 18) with the BamHI site ( underline) and reverse primer 5'-AGAATTCTAGGTCTGGCCATTTCTCAATG-3 '(SEQ ID NO: 19) with EcoRI site (underlined). Plasmid P326-ZmPSY1 (Zhu et al. 2008 Proc Natl Acad Sci USA 105: 18232-18237) is under the control of the LMW glutenin promoter (Colot et al. 1987 EMBO J 6: 3559-3564).
2) - Construccion pHorP-RNAi-Zmlyce que comprende el fragmento largo de 417 pb del ARNm de licopeno epsilon-ciclasa de maiz (SEQ ID NO: 16) elegido para construir la doble cadena de la construccion de ARNi conducida por el promotor de la D-hordema de cebada SEQ ID NO: 12) junto con el gen de selection bar (SEQ ID NO: 5) conducido por el promotor del gen ubiquitina-1 del maiz (SEQ ID NO: 24).2) - pHorP-RNAi-Zmlyce construct comprising the 417 bp long fragment of the corn lycopene epsilon-cyclase mRNA (SEQ ID NO: 16) chosen to construct the double strand of the RNAi construct driven by the promoter of the D-hordema of barley SEQ ID NO: 12) together with the selection bar gene (SEQ ID NO: 5) driven by the promoter of the ubiquitin-1 gene of the corn (SEQ ID NO: 24).
55
1010
15fifteen
20twenty
2525
3030
Un fragmento de ADNc LYCE (licopeno epsilon ciclasa de ma^z) se amplified por RT-PCR con ADNc de ZmLYCE como plantilla utilizando el cebador directo (5’- ggaattctctagacgatctcggcgccgctcggctgct-3’) (SEQ ID NO: 20) con los sitios EcoRI y Xbal (subrayado) y el cebador reverso (5’-gactagtggatcccaatgagacctacagtgagacct-3’) (SEQ ID NO:21) con sitios Spel y BamHI en base a information de la secuencia en GenBank (numeros de acceso EF622043 a fecha 4 septiembre 2009). Este ADN sentido se clono en el vector pHorP (S0rensen et al. 1996 Molec Gen Genetics 250:750 -760) que contiene el promotor de la hordema D de la cebada (SEQ ID NO: 12) con un fragmento de 306 pares de bases del gen gusA (SEQ ID NO: 25) y el terminador de la ADP-glucosa pirofosforilasa a traves de la restriction con XbaI y BamHI y el fragmento de LYCE antisentido en sitios SpeI y EcoRI.A fragment of LYCE cDNA (lycopene epsilon cyclase from ma ^ z) was amplified by RT-PCR with ZmLYCE cDNA as a template using the direct primer (5'-ggaattctctagacgatctcggcgccgctcggctgct-3 ') (SEQ ID NO: 20) with EcoRI sites and Xbal (underlined) and the reverse primer (5'-gactagtggatcccaatgagacctacagtgagacct-3 ') (SEQ ID NO: 21) with Spel and BamHI sites based on sequence information in GenBank (access numbers EF622043 as of September 4, 2009) . This sense DNA was cloned into the pHorP vector (S0rensen et al. 1996 Molec Gen Genetics 250: 750-760) containing the hordema D promoter of barley (SEQ ID NO: 12) with a 306 base pair fragment of the gusA gene (SEQ ID NO: 25) and the ADP-glucose pyrophosphorylase terminator through restriction with XbaI and BamHI and the antisense LYCE fragment at SpeI and EcoRI sites.
3) - Construction pGZ63-sCrbkt, que comprende sCrbkt truncado y sintetizado qmmicamente (beta-caroteno cetolasa) de Chlamydomonas reinhardtii fusionado con la subunidad pequena de la rubisco de guisante (SSU) y la region 5' no traducible (5'UTR) del gen de la alcohol deshidrogenasa del arroz, conducido por el promotor gamma-zema de maiz (la secuencia util del codon sCrbkt fue modificada para maiz).3) - Construction pGZ63-sCrbkt, which comprises truncated and chemically synthesized sCrbkt (beta-carotene ketolase) from Chlamydomonas reinhardtii fused with the small subunit of the pea rubisco (SSU) and the 5 'non-translatable region (5'UTR) of the Rice alcohol dehydrogenase gene, driven by the corn gamma-zema promoter (the useful sequence of the sCrbkt codon was modified for corn).
El gen truncado p-caroteno cetolasa (sCrBKT) Chlamydomonas reinhardtii sintetizado qmmicamente (Zhong et al. 2011 J Exp Bot 62:3659-3669) se fusiono a la subunidad pequena de guisante Rubisco (SSU) (Schreier et al. 1985 EMBO J 4:25-32) (el CrBKT y codon SSU se modifico a una preferencia de plantas monocotiledoneas, cuya secuencia se muestra en SEQ ID NO: 22) y la region 5' no traducida (5'UTR) del gen de la alcohol deshidrogenasa de arroz (SEQ ID NO: 17)(Surgio et al. 2008 J Biosci Bioeng 105:300302) se inserto en el vector pGZ63 (Zhu et al. 2008 Proc Natl Acad Sci USA 105:1823218237) entre el promotor de Y-zema y el terminador Nos utilizando los sitios de restriction BamHI y SacI.The truncated gene p-carotene ketolase (sCrBKT) Chlamydomonas reinhardtii chemically synthesized (Zhong et al. 2011 J Exp Bot 62: 3659-3669) was fused to the small subunit of Rubisco pea (SSU) (Schreier et al. 1985 EMBO J 4 : 25-32) (the CrBKT and codon SSU was modified to a preference of monocot plants, whose sequence is shown in SEQ ID NO: 22) and the 5 'untranslated region (5'UTR) of the alcohol dehydrogenase gene of Rice (SEQ ID NO: 17) (Surgio et al. 2008 J Biosci Bioeng 105: 300302) was inserted into the vector pGZ63 (Zhu et al. 2008 Proc Natl Acad Sci USA 105: 1823218237) between the Y-zema promoter and The terminator We are using the BamHI and SacI restriction sites.
4) - Construction pGZ63-sBrcrtZ. El gen beta-caroteno hidroxilasa (sBrcrtZ) sintetizado qmmicamente de Brevundimonas sp. SD212 fusionado con la SSU (subunidad pequena de la Rubisco) de guisante y 5'UTR del gen de la alcohol deshidrogenasa de arroz,4) - Construction pGZ63-sBrcrtZ. The beta-carotene hydroxylase (sBrcrtZ) gene chemically synthesized from Brevundimonas sp. SD212 fused with the SSU (small subunit of Rubisco) of pea and 5'UTR of the rice dehydrogenase alcohol gene,
55
1010
15fifteen
20twenty
2525
3030
conducido por el promotor de maiz gamma-zema espedfico del endospermo (los codones utiles del BrcrtZ se modificaron a tipo de planta dicotiledonea - colza).driven by the endosperm specific gamma-zema corn promoter (the useful codons of BrcrtZ were modified to dicotyledonea-rapeseed plant type).
El gen Crtz que codifica la beta-caroteno hidroxilasa de Brevundimonas sp. SD212 Strain (MBIC 03.018) (Nishida et al. 2005 Appl Environ Microbiol 71:4286-4296) fue sintetizado qmmicamente de acuerdo con el uso de codones de Brassic napus (numero de acceso AB377272 del a base de datos de GenBank 16, junio 2010) y amablemente proporcionados por el Dr. Norihiko Misawa, Universidad de la Prefectura de Ishikawa, Japon). El gen sBrCRTZ fusionado con la subunidad pequena de Rubisco (SSU) de guisante y la region 5'-no traducida (5'UTR) del gen de la alcohol deshidrogenasa de arroz se digirio con BamHI y SacI. La quimera formada por Crtz con codones optimizados y SSU corresponde a la SEQ ID NO: 23 Los fragmentos digeridos fueron clonados en el sitio BamHI y SacI de pGZ63 con el promotor del gen de gamma zema de maiz para generar pGZ63-sBrCRTZ. El gen bar que codifica fosfinotricina N-acetiltransferasa (Thompson et al., 1987 EMBO J 6:2513-2518) se utilizo como un marcador seleccionable.The Crtz gene encoding the beta-carotene hydroxylase from Brevundimonas sp. SD212 Strain (MBIC 03.018) (Nishida et al. 2005 Appl Environ Microbiol 71: 4286-4296) was chemically synthesized according to the use of Brassic napus codons (accession number AB377272 from the GenBank database 16, June 2010 ) and kindly provided by Dr. Norihiko Misawa, Ishikawa Prefecture University, Japan). The sBrCRTZ gene fused with the small Rubisco (SSU) pea subunit and the 5'-untranslated region (5'UTR) of the rice alcohol dehydrogenase gene was digested with BamHI and SacI. The chimera formed by Crtz with optimized codons and SSU corresponds to SEQ ID NO: 23 The digested fragments were cloned into the BamHI and SacI site of pGZ63 with the corn gamma zema gene promoter to generate pGZ63-sBrCRTZ. The bar gene encoding phosphinothricin N-acetyltransferase (Thompson et al., 1987 EMBO J 6: 2513-2518) was used as a selectable marker.
El procedimiento utilizado para la transformacion de maiz M37W se describe en Zhu et al. 2008, Proc Natl Acad Sci USA 105:18232-18237. Las plantas M37M-BKT- con mayor acumulacion de astaxantina se cruzaron con una lmea de alta aceite (NSL30876) para generar NSL30876-BKT.The procedure used for the transformation of M37W corn is described in Zhu et al. 2008, Proc Natl Acad Sci USA 105: 18232-18237. M37M-BKT- plants with the highest accumulation of astaxanthin were crossed with a high oil line (NSL30876) to generate NSL30876-BKT.
Seleccion de la linea elite de produccion de astaxantina y otros cetocarotenoidesSelection of the elite production line of astaxanthin and other ketocarotenoids
La mejor linea BKT con alta produccion de astaxantina y otros cetocarotenoides en el endospermo fue elegida para los cruzamientos con la linea de maiz con alto nivel de aceite NSL30876, tambien denominada R78 (Jugenheimer RW Euphytica 10 (1961): 152156, y el libro Specialty corns, Hallauer Arnel R. Caprtulo 5 "High-oil corn hybrids” Robert J. Lambert)The best BKT line with high production of astaxanthin and other ketocarotenoids in the endosperm was chosen for the crosses with the corn line with high oil level NSL30876, also called R78 (Jugenheimer RW Euphytica 10 (1961): 152156, and the book Specialty corns, Hallauer Arnel R. Chapter 5 "High-oil corn hybrids” Robert J. Lambert)
La linea hibrida NSL30876 x M37W BKT (F3) sobreexpresante produjo niveles de astaxantina de hasta 18.83^g/g peso seco. La cantidad de cetocarotenoides totales alcanzo aproximadamente 35^g/g peso seco (mas del 73% del total de carotenoides - 48.63^g/g peso seco). Fue confirmada la expresion espedficamente en el endospermoThe NSL30876 x M37W BKT (F3) overexpressing hybrid line produced astaxanthin levels of up to 18.83 ^ g / g dry weight. The amount of total ketocarotenoids reached approximately 35 ^ g / g dry weight (more than 73% of the total carotenoids - 48.63 ^ g / g dry weight). The expression was specifically confirmed in the endosperm
55
1010
15fifteen
20twenty
2525
3030
del maiz mediante analisis de ARNm de transferencia de todos los transgenes introducidos involucrados en la ruta metabolica diana.of corn by transfer mRNA analysis of all introduced transgenes involved in the target metabolic pathway.
Analisis de la calidad de huevoEgg quality analysis
Para determinar la calidad del huevo se midio el grosor de la cascara mediante un micrometro espedfico 4001-DIG (Baxlo Precision, Polinya, Espana), con una sensibilidad de 1j y provisto de contactos para superficies curvas. El peso del huevo, el color segun la ESCALA DSM (del ingles DSM yolk color fan (DYCF), la altura del albumen y las Unidades Haugh (UH = 100 x Log [Altura de la clara densa -1.7 x (peso huevo) 0,37 + 7,57] se midieron con el Egg Analyzer™ (ORKA Technology Ltd., Ramat Hasharon, Israel).To determine the quality of the egg, the thickness of the shell was measured by means of a 4001-DIG specific micrometer (Baxlo Precision, Polinya, Spain), with a sensitivity of 1j and provided with contacts for curved surfaces. Egg weight, color according to DSM SCALE (DSM yolk fan color (DYCF), albumen height and Haugh Units (UH = 100 x Log [Dense clear height -1.7 x (egg weight) 0 , 37 + 7.57] were measured with the Egg Analyzer ™ (ORKA Technology Ltd., Ramat Hasharon, Israel).
Analisis de carotenoidesCarotenoid Analysis
Las muestras para el analisis de carotenoides se recogieron el dia 0 del experimento para comprobar el nivel de carotenos de la yema de huevo que teman los animales en granja, a dia 13 para poder comprobar si el periodo de deplecion habia conseguido disminuir los carotenos en la yema, y a dia 20 y 30 para ver la evolucion y diferencias en las cantidades de carotenos de los distintos tratamientos experimentados. Las muestras se congelaron a -80°C, posteriormente se liofilizaron y se enviaron a analizar. La tecnica de analisis fue la siguiente:The samples for the analysis of carotenoids were collected on day 0 of the experiment to check the level of carotenoids of the egg yolk that the animals fear in the farm, on day 13 to be able to verify if the period of depletion had managed to decrease the carotenes in the yolk, already day 20 and 30 to see the evolution and differences in the amounts of carotenes of the different treatments experienced. The samples were frozen at -80 ° C, subsequently lyophilized and sent for analysis. The analysis technique was as follows:
Los carotenoides totales, fueros extractados en 20 ml de metanol conteniendo un 6% de KOH a 60°C y durante 15-20 minutos. Los compuestos lipofflicos, se separaron en una solucion con 30% de eter en petroleo y la fase superior fue recogida. Los carotenoides totales fueron determinados midiendo la absorbancia a 450 nm. Para la separacion por HPLC, el solvente fue evaporado en vapor de nitrogeno a 37°C, disuelto en 100 jL de metanol/diclorometano (50:50) y una alicuota de 20 jl fue inyectada inmediatamente. Los compuestos fueron separados en una columna de 15 cm Nucleosil C18 3-|j con acetonitril/metanol/2-propanol (85:15:5) v/v/v en fase movil a 20°C. Las muestras fueron monitorizadas con un Kontron DAD 440 fotodiodo detector, con registro online del espectro. Todos los carotenoides fueron identificados por cromatografia con compuestos autenticos de refencia, los cuales fueron biosintetizados en E.coli como describeTotal carotenoids, were extracted in 20 ml of methanol containing 6% KOH at 60 ° C and for 15-20 minutes. The lipophilic compounds were separated in a solution with 30% ether in petroleum and the upper phase was collected. Total carotenoids were determined by measuring absorbance at 450 nm. For separation by HPLC, the solvent was evaporated in nitrogen vapor at 37 ° C, dissolved in 100 jL of methanol / dichloromethane (50:50) and an aliquot of 20 jl was injected immediately. The compounds were separated on a 15 cm column Nucleosil C18 3- | j with acetonitril / methanol / 2-propanol (85: 15: 5) v / v / v in mobile phase at 20 ° C. The samples were monitored with a Kontron DAD 440 photodiode detector, with online spectrum recording. All carotenoids were identified by chromatography with authentic reference compounds, which were biosynthesized in E.coli as described
55
1010
15fifteen
20twenty
2525
3030
Sandmann (Sandmann, G. (2002) Combinatorial biosynthesis of carotenoids in a heterologous host: a powerful approach for the biosynthesis of novel structures. ChemBioChem. 3: 629-635) y sus espectros fueron comparados. Esos estandares tambien fueron usados para la cuantificacion, en combination con los coeficientes de extincion de Davies (Davies, B.H. (1976) Carotenoids. In: Chemistry of Plant Pigments (Goodwin, T.W., ed), pp. 149-155. London, UK: Academic Press). El retinol fue comprado a Sigma Chemicals. El acido retinoico conjugado (RAC), derivado del retinol, fue identificado por el espectro tipico del acido retinoico con picos maximos a 328, 350 y 368 nm. Fue cuantificado usando retinol como estandar con correction por el coeficiente de extincion mM para el retinol (45,0 para 325 nm) y acido retinoico (53,5 para 350 nm)Sandmann (Sandmann, G. (2002) Combinatorial biosynthesis of carotenoids in a heterologous host: a powerful approach for the biosynthesis of novel structures. ChemBioChem. 3: 629-635) and their spectra were compared. These standards were also used for quantification, in combination with Davies extinction coefficients (Davies, BH (1976) Carotenoids. In: Chemistry of Plant Pigments (Goodwin, TW, ed), pp. 149-155. London, UK : Academic Press). Retinol was purchased from Sigma Chemicals. Conjugated retinoic acid (RAC), derived from retinol, was identified by the typical spectrum of retinoic acid with maximum peaks at 328, 350 and 368 nm. It was quantified using retinol as a standard with correction by the extinction coefficient mM for retinol (45.0 for 325 nm) and retinoic acid (53.5 for 350 nm)
EJEMPLO 1EXAMPLE 1
Como se demuestra a continuation es posible el aporte de Vitamina A, carotenos y cetocarotenoides a las gallinas ponedoras de forma exclusiva y completa a traves del maiz incorporado en la dieta, mediante el uso de dos variedades obtenidas por ingenieria genetica y que expresan elevadas cantidades de carotenos y cetocarotenoides. La suficiencia en el aporte de carotenos desde el punto de vista del consumidor viene marcada cuando se alcanzan los valores comerciales habituales de color amarillo-naranja en la yema de huevo fresco y que se miden generalmente de acuerdo con la escala la escala DSM (en ingles DSM yolk color fan (DYCF)) de color.As shown below, the contribution of Vitamin A, carotenes and ketocarotenoids to laying hens is possible exclusively and completely through corn incorporated into the diet, through the use of two varieties obtained by genetic engineering and expressing high amounts of carotenes and ketocarotenoids. The sufficiency in the contribution of carotenes from the point of view of the consumer is marked when the usual commercial values of yellow-orange color in the fresh egg yolk are reached and that the DSM scale is generally measured according to the scale (in English DSM yolk color fan (DYCF)) color.
Las dos variedades de maiz estudiadas son las siguientes: M37W-Ph-3 y NSL30876 x BKT.The two varieties of corn studied are the following: M37W-Ph-3 and NSL30876 x BKT.
Los carotenoides mayores en la lmea silvestre NSL30876 son lutema y zeaxantina y de la lmea silvestre M37W lutema y zeaxantinaThe major carotenoids in the wild lmea NSL30876 are lutema and zeaxanthin and from the wild lmea M37W lutema and zeaxanthin
La lmeas transgenicas desarrolladas presentan los siguientes carotenoides:The developed transgenic lines have the following carotenoids:
- BKT: violaxantina, anteraxantina, lutema, zeaxantina, p-caroteno, astaxantina, cantaxanthin, p-cryptoxantina, Z-fitoeno, Adonixantina, adonirubina, 3-OH- equinenona, p-zeacaroteno, fitoeno- BKT: violaxanthin, anteraxanthin, lutema, zeaxanthin, p-carotene, astaxanthin, cantaxanthin, p-cryptoxanthin, Z-phytoeno, Adonixanthin, adonirubin, 3-OH- equinenone, p-zeacarotene, phytoen
- M37W-Ph-3: lutema, zeaxantina, p-carotenos, licopeno y alfa y beta criptoxantina- M37W-Ph-3: lutema, zeaxanthin, p-carotenes, lycopene and alpha and beta cryptoxanthin
55
1010
15fifteen
20twenty
2525
3030
- NSL30876 x BKT: astaxantina violaxantina, antheraxantina , lutema, zeaxantina,- NSL30876 x BKT: astaxanthin violaxanthin, antheraxanthin, lutema, zeaxanthin,
P-caroteno, p-cryptoxantina, 3-OH-equinenona y otros cetocarotenoides como cantaxantina, adonixantina, adonirubinaP-carotene, p-cryptoxanthin, 3-OH-equinenone and other ketocarotenoids such as cantaxanthin, adonixanthin, adonirubin
El ensayo se realizo con gallinas ponedoras de tipo comercial en las instalaciones de la Universidad de Lleida (Espana). En las dietas experimentales se uso un 62% de maiz. Los diferentes tipos de maiz empleados fueron los siguientes: maiz isogenico control blanco, maiz M37W-Ph-3, ma^z NSL30876 x BKT y maiz estandar comercial. Se recogieron muestras de pienso, de yemas de los huevos y de higados que se liofilizaron para su posterior analisis de carotenosThe test was conducted with commercial laying hens at the facilities of the University of Lleida (Spain). In experimental diets 62% corn was used. The different types of corn used were the following: white control isogenic corn, M37W-Ph-3 corn, NSL30876 x BKT corn and commercial standard corn. Samples of feed, egg yolks and liver were collected and lyophilized for subsequent carotene analysis.
Se determino el contenido en carotenos en muestras de pienso (Figura 1) yema de huevos (Figura 2) y en higados liofilizados (Figura 3).Carotene content was determined in feed samples (Figure 1) and egg yolk (Figure 2) and in lyophilized liver (Figure 3).
El uso en la dieta de las gallinas ponedoras de maiz rico en pigmentos antioxidantes, (M37W-Ph-3) producen huevos con una mayor calidad nutricional derivada del aporte de carotenoides (57,5 ^g/g de materia seca de yema).The use in the diet of corn laying hens rich in antioxidant pigments, (M37W-Ph-3) produce eggs with a higher nutritional quality derived from the contribution of carotenoids (57.5 ^ g / g of dried yolk matter).
El uso en la dieta de las gallinas ponedoras de maiz rico en antioxidantes, NSL30876 x BKT produce huevos con una mayor calidad nutricional derivada del aporte de carotenoides (24,49 ^g/g de materia seca de yema).The use of antioxidant-rich corn hens in the diet, NSL30876 x BKT produces eggs with a higher nutritional quality derived from the contribution of carotenoids (24.49 ^ g / g of dried yolk matter).
En cambio la variedad salvaje de maiz blanco M37W produce huevos de yema decolorada, (Valor DSM <1) y concentration total de carotenoides en la yema 1,81 ^g/g de materia seca de yema).In contrast, the wild variety of white corn M37W produces bleached yolk eggs, (DSM value <1) and total concentration of carotenoids in the yolk 1.81 ^ g / g of dried yolk matter).
El uso en la dieta de las gallinas ponedoras de maiz rico en antioxidantes, M37W-Ph-3 produce yemas de huevos con alto contenido en zeaxantina (29,89 ^g/g de materia seca de yema).The use of antioxidant-rich corn laying hens in the diet, M37W-Ph-3 produces egg yolks high in zeaxanthin (29.89 ^ g / g of dried yolk).
El uso en la dieta de las gallinas ponedoras de maiz rico en antioxidantes, NSL30876 *BKT produce yemas de huevos con alto contenido en carotenos, zeaxantina (10,77±1,33The use of antioxidant-rich corn hens in the diet, NSL30876 * BKT produces egg yolks high in carotenes, zeaxanthin (10.77 ± 1.33
^g/g de materia seca de yema) y cetocarotenos, astaxantina (6,56±0,56 ^g/g de materia seca de yema)^ g / g of yolk dry matter) and ketocarotenes, astaxanthin (6.56 ± 0.56 ^ g / g of yolk dry matter)
En la tabla 1 se pueden observar los datos de calidad del huevo al Inicio (a la entrada del 5 experimento, ya que las gallinas proveman de una granja con pienso estandar de ponedoras), Deplecion (a los 13 dias del ensayo despues de la ingestion del pienso con maiz blanco maiz control blanco, M37W y Tratamiento (despues del final del ensayo y de 20 dias de consumo de los piensos elaborados con los diferentes tipos de maiz.Table 1 shows the quality data of the egg at the beginning (at the entrance of the experiment, since the hens provide a farm with standard layers of laying hens), Depletion (13 days after testing after ingestion of the feed with white corn, white control corn, M37W and Treatment (after the end of the test and 20 days of consumption of the feed made with the different types of corn.
10 En el experimento no se observaron diferencias en los distintas medidas de calidad del huevo excepto en el color segun ESCALA DSM, en el que se observa que se llegan a conseguir los valores comerciales previos e incluso superarlos en el color de la yema en ambos casos con solo el maiz (M37W-Ph-3 y NSL30876xBKT).10 In the experiment no differences were observed in the different measures of egg quality except in the color according to DSM SCALE, in which it is observed that the previous commercial values are achieved and even exceeded in the color of the yolk in both cases with only corn (M37W-Ph-3 and NSL30876xBKT).
- M37W M37W-Ph3 NSL30876xBKT Malz comercial M37W M37W-Ph3 NSL30876xBKT Malz commercial
- Peso huevo (g) Egg Weight (g)
- Inicio 63,81±1,124 61,76±1,531 64,75±1,478 65,17±1,350 Start 63.81 ± 1,124 61.76 ± 1,531 64.75 ± 1,478 65.17 ± 1,350
- Deplecion Depletion
- 60,90±1,682 61,35±1,578 64,05±1,281 64,91±1,523 60.90 ± 1.682 61.35 ± 1.578 64.05 ± 1.281 64.91 ± 1.523
- Tratamiento 68,06±1,352 63,71±1,168 66,85±1,274 68,92±1,479 Treatment 68.06 ± 1,352 63.71 ± 1,168 66.85 ± 1,274 68.92 ± 1,479
- Resistencia rotura (Kg) Breaking Strength (Kg)
- Inicio 3,35±0,245 3,23±0,405 3,53±0,314 3,68±0,190 Start 3.35 ± 0.245 3.23 ± 0.405 3.53 ± 0.314 3.68 ± 0.190
- Deplecion Depletion
- 3,01±0,157 3,86±0,215 3,81±0,227 3,56±0,280 3.01 ± 0.157 3.86 ± 0.215 3.81 ± 0.227 3.56 ± 0.280
- Tratamiento 3,71±0,258 3,87±0,195 3,81±0,146 3,25±0,185 Treatment 3.71 ± 0.258 3.87 ± 0.195 3.81 ± 0.146 3.25 ± 0.185
- Altura Height
- Inicio 5,88±0,340 6,59±0,636 6,16±0,632 6,98±0,296 Start 5.88 ± 0.340 6.59 ± 0.636 6.16 ± 0.632 6.98 ± 0.296
- albumen (Hmm) albumen (Hmm)
- Deplecion 5,12±0,322 5,72±0,275 5,58±0,367 5,62±0,256 Depletion 5.12 ± 0.322 5.72 ± 0.275 5.58 ± 0.367 5.62 ± 0.256
- Tratamiento Treatment
- 6,08±0,417 5,70±0,229 5,01±0,511 5,56±0,214 6.08 ± 0.417 5.70 ± 0.229 5.01 ± 0.511 5.56 ± 0.214
- Inicio 9,83±0,207 9,86±0,143 10,13±0,227 10,11±0,000 Start 9.83 ± 0.207 9.86 ± 0.143 10.13 ± 0.227 10.11 ± 0.000
- Color DSM DSM color
- Deplecion 1,08±0,077 1,33±0,256 1,64±0,308 1,00±0,261 Depletion 1.08 ± 0.077 1.33 ± 0.256 1.64 ± 0.308 1.00 ± 0.261
- Tratamiento 1,25±0,250 10,08±0,313 11,38±0,241 4,22±0,222 Treatment 1.25 ± 0.250 10.08 ± 0.313 11.38 ± 0.241 4.22 ± 0.222
Inicio 73,97±2,608 74,61±4,728 74,80±4,943 81,10±2,472Start 73.97 ± 2,608 74.61 ± 4,728 74.80 ± 4,943 81.10 ± 2,472
Deplecion 69,02±3,073 75,28±1,578 70,76±2,983 71,97±1,794Depletion 69.02 ± 3,073 75.28 ± 1,578 70.76 ± 2,983 71.97 ± 1,794
Tratamiento 73,08±3,328 69,73±3,335 66,22±3,601 69,69±1,787Treatment 73.08 ± 3,328 69.73 ± 3,335 66.22 ± 3,601 69.69 ± 1,787
Inicio 320,33±10,227 315,29±22,561 343,25±11,965 319,67±13,317Start 320.33 ± 10,227 315.29 ± 22,561 343.25 ± 11,965 319.67 ± 13,317
GrosorThickness
cascara Deplecion 347,36±7,443 339,12±11,078 356,68±11,242 332,60±7,294Shell Depletion 347.36 ± 7,443 339.12 ± 11,078 356.68 ± 11,242 332.60 ± 7,294
(mm) ___________________________________________________________________(mm) ___________________________________________________________________
Tratamiento 359,58±19,434 357,46±10,377 364,08±10,117 359,25±10,547Treatment 359.58 ± 19,434 357.46 ± 10,377 364.08 ± 10,117 359.25 ± 10,547
Tabla 1.Table 1.
UnidadesUnits
HaughHaugh
Durante el ensayo, el color de la yema se determino obteniendo las coordenadas L*, a*, b* en el espacio CIELAB mediante un colorimetro Konica Minolta CM-700d (Konica 5 Minolta Sensing Inc., Osaka, Japan) con un area de medida de 8 mm, iluminante D65 y angulo de observation de 10°. Como contenedor de la yema se utilizo una capsula de cristal optico cilmdrica de 34 mm de diametro (Hellma, Mullheim, Germany).During the test, the color of the yolk was determined by obtaining the coordinates L *, a *, b * in the CIELAB space using a Konica Minolta CM-700d colorimeter (Konica 5 Minolta Sensing Inc., Osaka, Japan) with an area of 8 mm measurement, illuminant D65 and observation angle of 10 °. As a yolk container, a cylindrical optical glass capsule with a diameter of 34 mm (Hellma, Mullheim, Germany) was used.
En la tabla 2 se muestran los valores de L*, a* y b* medios para cada tratamiento al final 10 del experimento (dias 32 y 33 del experimento). Se puede apreciar que la L* se mantiene constante en todos los tratamientos, en cambio los valores de a* y b* fluctuan segun el tratamiento y el contenido de carotenos presentes en los maices de las dietas.Table 2 shows the values of L *, a * and b * means for each treatment at the end 10 of the experiment (days 32 and 33 of the experiment). It can be seen that L * remains constant in all treatments, instead the values of a * and b * fluctuate according to the treatment and the content of carotenes present in the cornices of the diets.
- L* a* b* L * a * b *
- M37W M37W
- 57,96±0,598 -1,16±0,073 9,72±0,951 57.96 ± 0.598 -1.16 ± 0.073 9.72 ± 0.951
- M37W-Ph3 M37W-Ph3
- 51,69±0,554 10,82±0,435 22,67±1,407 51.69 ± 0.554 10.82 ± 0.435 22.67 ± 1.407
- NSL30876 x NSL30876 x
- BKT BKT
- 49,37±0,938 13,63±0,620 17,45±0,895 49.37 ± 0.938 13.63 ± 0.620 17.45 ± 0.895
- Malz comercial Commercial malz
- 56,78±0,696 3,58±0,176 25,43±2,382 56.78 ± 0.696 3.58 ± 0.176 25.43 ± 2.382
Tabla 2.Table 2.
15 El uso de las variedades de maiz M37W-Ph-3 y NSL30876 x BKT a concentraciones del 62% en la dieta hace innecesario el uso de los pigmentos exogenos para conseguir15 The use of corn varieties M37W-Ph-3 and NSL30876 x BKT at concentrations of 62% in the diet makes the use of exogenous pigments unnecessary to achieve
huevos con yemas dentro de la gama de color aceptada por el consumidor. Este efecto no es conseguido por el maiz estandar convencional empleado en la misma proporcion en la dieta.Eggs with yolks within the color range accepted by the consumer. This effect is not achieved by the conventional standard corn used in the same proportion in the diet.
5 El empleo de las variedades de ma^z desarrolladas, permite reducir el coste de pienso fabricado al eliminar el coste que supone anadir los carotenos exogenamente y simplifica el proceso de fabrication de pienso.5 The use of developed varieties of corn makes it possible to reduce the cost of manufactured feed by eliminating the cost of adding carotenes exogenously and simplifying the feed manufacturing process.
El termino "Sequence listing” en la lista de secuencias se refiere a "Lista de secuencias”, "Artificial Sequence” a "Secuencia artificial” y el termino "DNA” se refiere a "ADN”.The term "Sequence listing" in the sequence list refers to "Sequence list", "Artificial Sequence" to "Artificial sequence" and the term "DNA" refers to "DNA".
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201531699A ES2558953B1 (en) | 2015-11-23 | 2015-11-23 | Corn enriched in antioxidants to improve the nutritional quality of the egg |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201531699A ES2558953B1 (en) | 2015-11-23 | 2015-11-23 | Corn enriched in antioxidants to improve the nutritional quality of the egg |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2558953A1 ES2558953A1 (en) | 2016-02-09 |
ES2558953B1 true ES2558953B1 (en) | 2016-11-18 |
Family
ID=55237385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201531699A Expired - Fee Related ES2558953B1 (en) | 2015-11-23 | 2015-11-23 | Corn enriched in antioxidants to improve the nutritional quality of the egg |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2558953B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110423766A (en) * | 2019-08-29 | 2019-11-08 | 南京大学 | A kind of lycopene beta cyclase gene and its coding albumen and application |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2495444A1 (en) * | 2002-08-20 | 2004-03-04 | Sungene Gmbh & Co.Kgaa | Method for producing ketocarotinoids in plant fruit |
US8872006B1 (en) * | 2009-06-23 | 2014-10-28 | Pioneer Hi Bred International Inc | Maize variety inbred PH11V8 |
CN102321649B (en) * | 2011-09-22 | 2013-11-13 | 天津大学 | Lycium chinense miller lycopene beta-cyclase gene, recombinant vector containing gene, host cell and application |
-
2015
- 2015-11-23 ES ES201531699A patent/ES2558953B1/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110423766A (en) * | 2019-08-29 | 2019-11-08 | 南京大学 | A kind of lycopene beta cyclase gene and its coding albumen and application |
CN110423766B (en) * | 2019-08-29 | 2021-06-29 | 南京大学 | Lycopene beta-cyclase gene and coding protein and application thereof |
Also Published As
Publication number | Publication date |
---|---|
ES2558953A1 (en) | 2016-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Birla et al. | Progress and challenges in improving the nutritional quality of rice (Oryza sativa L.) | |
Rodomiro | Transgenic vegetable breeding for nutritional quality and health benefits | |
US6218599B1 (en) | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants | |
Stålberg et al. | Synthesis of ketocarotenoids in the seed of Arabidopsis thaliana | |
US9580725B2 (en) | Methods and compositions for modifying plant flavonoid composition and disease resistance | |
Badejo | Elevated carotenoids in staple crops: The biosynthesis, challenges and measures for target delivery | |
MXPA05001948A (en) | Use of astaxanthin-containing plants or parts of plants of the genus tagetes. | |
CN108882691A (en) | Rice grain with the aleurone thickened | |
Bollineni et al. | Marker assisted biofortification of rice with pro-vitamin A using transgenic Golden Rice® lines: progress and prospects | |
CN109640635A (en) | High amylose starches wheat-III | |
Liu et al. | Metabolic engineering of astaxanthin‐rich maize and its use in the production of biofortified eggs | |
Dwivedi et al. | Developing germplasm and promoting consumption of anthocyanin-rich grains for health benefits | |
Mattoo et al. | Genetic engineering to enhance crop-based phytonutrients (nutraceuticals) to alleviate diet-related diseases | |
ES2558953B1 (en) | Corn enriched in antioxidants to improve the nutritional quality of the egg | |
Uncu et al. | Biotechnology for enhanced nutritional quality in plants | |
JP2005204657A (en) | Method for producing plant body decreased in tannin content, the plant body obtained by using the method and use of the plant body | |
Federico et al. | Modern breeding and biotechnological approaches to enhance carotenoid accumulation in seeds | |
Hefferon | Crops with improved nutritional content though agricultural biotechnology | |
ES2626277T3 (en) | Gene that transmits resistance to hydrogen peroxide and a method to use it | |
Shwetha et al. | Biofortification of Carotenoids in Agricultural and Horticultural Crops: A Promising Strategy to Target Vitamin A Malnutrition | |
WO2007006094A1 (en) | Wheat pigment | |
US20070157339A1 (en) | Biochemical route to astaxanthin | |
EP2932825B1 (en) | Unhulled rice of biosynthesizing resveratrol, and use thereof | |
WO2001009358A1 (en) | Nucleic acid constructs for the modification of polyamine levels in plants | |
WO2015185779A1 (en) | Method for treating coccidiosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2558953 Country of ref document: ES Kind code of ref document: B1 Effective date: 20161118 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20240327 |